Reply-To: "Sandy Ayer" From: "Sandy Ayer" To: Subject: Fw: ** IMPORTANT!!!!!vaccine chart Date: Sun, 9 Oct 2005 11:15:48 -0400 MIME-Version: 1.0 Content-Type: multipart/related; type="multipart/alternative"; boundary="----=_NextPart_000_012D_01C5CCC2.CCEF8C60" X-Priority: 3 X-MSMail-Priority: Normal X-Mailer: Microsoft Outlook Express 6.00.2900.2527 X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2527 This is a multi-part message in MIME format. ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: multipart/alternative; boundary="----=_NextPart_001_012E_01C5CCC2.CCEF8C60" ------=_NextPart_001_012E_01C5CCC2.CCEF8C60 Content-Type: text/plain; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable Subject: Fw: IMPORTANT!!!!!vaccine chart A LINK TO ANOTHER SITE AS = WELL>>>>http://www.leerburg.com/special_report.htm Critter Advocacy.org Responsibility Ethics Science =20 =20 =20 =20 Quick Links Canine Vaccination Guidelines The duration of immunity for vaccines for diseases like = rabies, distemper, and parvovirus have been shown to be 7 years. More = importantly it has been scientifically proven that, after the initial = series, when vaccines are re-administered the immune status of the = patient is not enhanced. Antibodies from the initial vaccine block the = subsequent vaccines from having any effect.=20 Although the true interval at which re-administration of = Rabies, Distemper, Parvovirus, Adenovirus and Para influenza = vaccinations will enhance the immunity in a significant number of dogs = has not been determined, an arbitrary compromise interval of every three = years has been agreed upon by the American Animal Hospital Association, = the American Association of Feline Practitioners, and 22 Schools of = Veterinary Medicine. It is the consensus of immunologists and experts = that the duration of immunity is much longer and probably the life of = the patient. This three-year compromise interval will greatly reduce the = number of antigens administered, and therefore the risk of adverse = reactions, while providing the most complete protection against = preventable diseases possible.=20 These are the recommendations of Bob Rogers DVM based on Peer Reviewed Journal Publications (References) The American Association of Feline Practitioners The American Veterinary Medical Association Council on Biologic and Therapeutic Agents Texas A&M University Colorado State University Cornell University The American Animal Hospital Association=20 Vaccination Schedule:=20 Core vaccines =96 recommended for all dogs =20 =20 Vaccine =20 Initial =20 >12 Weeks =20 1st Annual =20 Re- Administration Interval Comments =20 =20 Rabies (killed) 16 weeks One vaccination 1 yr after the initial=20 vaccination =20 Every 3 years. Due to age & maternal antibodies, closer to 4 months = is better=20 Distemper (MLV) 8 weeks 12 weeks 16 weeks 2 doses 3-4 weeks apart Yes.=20 Will provide lifetime immunity. AAHA- Every three years (compromise) =20 =20 Recombinant vaccine for breeds like Weimaraners may prevent HOD =20 =20 Parvovirus (MLV 8 weeks 12 weeks 16 weeks 2 doses 3-4 weeks apart Yes =96=20 DOI 7 yrs+ Probably lifetime =20 None needed. Duration of immunity 7.5 years by studies. Probably lifetime. = Longer studies pending. At 6 weeks of age, only 30% of puppies are = protected but 100% are exposed to the virus at the vet clinic.=20 Non-Core Only recommended where there is a chance of exposure=20 Bordetella (Intranasal) (killed) Intra Nasal 4 days prior to boarding Inj. 3 weeks prior to Boarding Inj followed by Intra Nasal = demonstrated better protection Mfg recommends one dose Yes Immune response is faster with boosters =20 Annually (Para influenza every 3 years?) =20 Para influenza only protects against 1 of 8+ causes of Kennel Cough Bordetella =20 =20 Intranasal Bordetella takes effect in 72 hrs to take effect vs. = injectable requires 2 weeks to take effect. Recommended 3 days prior to boarding, grooming & dog shows. Protects against 2 of the possible 8 causes of kennel cough. Duration of immunity 6 months.=20 Leptospirosis 1.) There are an average of 12 cases of Lepto = annually in Texas. 2.) Side effects are common. 3.) The most commonly used vaccine contains the wrong serovars. = (There is no cross-protection of serovars) There is a new vaccine with 2 = new serovars. Two vaccinations twice per year would be required for = protection.)=20 4.) The risk of side effects outweighs benefits.=20 Lyme 1.) Vector tick/reservoir relationship not in Texas 2.) 85% of cases are in 9 New England area States, Minnesota and = Wisconsin. 3.) There is a possible side effect of polyarthritis from the = vaccine.=20 Vaccines Not Recommended For Dogs=20 Distemper & Parvo @ 6 weeks or younger Not recommended. At this age, maternal antibodies form the mothers milk (colostrum) = will neutralize the vaccine and only 30% for puppies will be protected. = 100% will be exposed to the virus at the vet clinic.=20 Corona Not recommended. 1. Disease only affects dogs < 8 weeks of age. 2. Corona is a rare disease, only 1 case reported in 7 yrs at each = of these Vet Schools: TAMU, Cornell, Colo.St., U.Cal.@ Davis 3. Efficacy of vaccine questionable, IgA Mucosal antibodies needed = Giardia Not recommended 1. Efficacy of Vaccine unsubstantiated by independent studies. 2. IgA mucosal antibodies? Immunity against a complex organism? 3. Natural infection does not provide immunity. =20 Extra vaccinations for Rottweilers at 20 weeks, etc-Are not = necessary if high titer Parvovirus vaccines are used. =20 =93Booster Vaccination=94 before breeding- does not increase = maternal antibody transfer in=20 colostrum.=20 Nosodes =96 Study by Dr. Ron Schultz demonstrated no = efficacy. =20 Not recommended: Greene=92s Infectious Diseases =20 Distemper and Parvo at 6 weeks =96 exposure to disease will = be increased by visiting a Veterinary=20 Hospital while only 30% of puppies will be protected, due to = maternal antibody interference with=20 vaccine. Vaccination by a breeder at home with Parvo only = may help prevent losses but will delay=20 next vaccination to 9 weeks. =20 =20 =20 =20 =20 CritterAdvocacy.org is dedicated to the education of pet owners=20 and the care-takers that help them.=20 e-mail drbob@critteradvocacy.org Copyright (c) 2003. Dr. Robert L. Rogers. All rights reserved. =20 The Better Business Bureau. Education Foundation Torch Awards for Excellence in Business Ethics=20 Presented to Dr. Bob Rogers=20 for Public Education about New Vaccination Recommendations =20 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.732 / Virus Database: 486 - Release Date: 8/3/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.735 / Virus Database: 489 - Release Date: 8/7/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.740 / Virus Database: 494 - Release Date: 8/17/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.752 / Virus Database: 503 - Release Date: 9/3/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.767 / Virus Database: 514 - Release Date: 9/22/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.770 / Virus Database: 517 - Release Date: 9/28/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.775 / Virus Database: 522 - Release Date: 10/9/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.778 / Virus Database: 525 - Release Date: 10/15/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.782 / Virus Database: 528 - Release Date: 10/23/2004 --- Outgoing mail is certified Virus Free. Checked by AVG anti-virus system (http://www.grisoft.com). Version: 6.0.824 / Virus Database: 562 - Release Date: 1/1/2005 ------=_NextPart_001_012E_01C5CCC2.CCEF8C60 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable
 

 

 

 

Subject: Fw: IMPORTANT!!!!!vaccine chart
A LINK TO ANOTHER = SITE AS=20 WELL>>>>http://www.leerburg.c= om/special_report.htm
 

Critter
  Advocacy.org
 =20 Responsibility
  Ethics
  = Science

 

 

Quick=20 Links







3DConclusions=20
3DReferences=20

3D"Canine

3D"FAQ's"=20
3DLibrary=20
3D"Web



3D"Thanks

3DMemorials=20


3D"The

Canine = Vaccination=20 Guidelines

The=20 duration of immunity for vaccines for diseases like rabies,=20 distemper, and parvovirus have been shown to be 7 years. = More=20 importantly it has been scientifically proven that, after = the=20 initial series, when vaccines are re-administered the immune = status=20 of the patient is not enhanced.  Antibodies from the = initial=20 vaccine block the subsequent vaccines from having any = effect.=20

Although the true interval at which = re-administration of=20 Rabies, Distemper, Parvovirus, Adenovirus and Para influenza = vaccinations will enhance the immunity in a significant = number of=20 dogs has not been determined, an arbitrary compromise = interval of=20 every three years has been agreed upon by the American = Animal=20 Hospital Association, the American Association of Feline=20 Practitioners, and 22 Schools of Veterinary Medicine. It is = the=20 consensus of immunologists and experts that the duration of = immunity=20 is much longer and probably the life of the patient. This = three-year=20 compromise interval will greatly reduce the number of = antigens=20 administered, and therefore the risk of adverse reactions, = while=20 providing the most complete protection against preventable = diseases=20 possible.=20

These are the recommendations of = Bob Rogers=20 DVM based on
Peer Reviewed Journal Publications=20 (References)
The American Association of Feline=20 Practitioners
The American Veterinary Medical=20 Association
Council on Biologic and Therapeutic = Agents
Texas=20 A&M University
Colorado State University
Cornell=20 University
The American Animal Hospital = Association=20

Vaccination = Schedule:=20

Core vaccines =96 recommended for = all=20 = dogs

=

AAHA-

Every = three years=20 = (compromise)

Vaccine

 
Initial

 
>12=20 Weeks

 
1st=20 Annual

 
Re-
Administration=20 Interval
Comments

 

Rabies
(killed)		 16=20 weeks One=20 vaccination

1 yr after the = initial=20

vaccination

 

 Every 3=20 years. Due to age & maternal = antibodies,=20 closer to 4 months is = better
Distemper
(MLV)		 8 weeks
12=20 weeks
16 weeks		 2 doses 3-4=20 weeks apart Yes.
Will=20 provide lifetime immunity.

 

Recombinant = vaccine for=20 breeds like Weimaraners may prevent

HOD

 

Parvovirus
(MLV 8 weeks
12=20 weeks
16 weeks 2 doses 3-4=20 weeks apart

Yes =96 =

DOI 7 = yrs+

Probably=20 lifetime

 

None=20 needed.
Duration of immunity 7.5 years by studies. Probably = lifetime.=20 Longer studies pending. At 6 weeks of=20 age, only 30% of puppies are protected but 100% are exposed to the = virus=20 at the vet = clinic.
Non-Core Only=20 recommended where there is a chance of=20 = exposure
<= !--mstheme-->
Bordetella
(Intranasal)
(killed)		 Intra=20 Nasal 4 days prior to boarding
Inj. 3 = weeks prior=20 to Boarding Inj followed by Intra Nasal demonstrated better=20 protection		 Mfg = recommends=20 one dose

Yes

Immune=20 response is faster with boosters

 

Annually

(Para=20 influenza every 3 years?)

 

Para=20 influenza only protects against 1 of 8+ = causes of=20 Kennel Cough

Bordetella

 

Intranasal=20 Bordetella takes effect in 72 hrs to take effect vs. injectable = requires 2=20 weeks to take effect.
Recommended 3 days prior to boarding, = grooming=20 & dog shows.
Protects against 2 of the possible 8 causes of = kennel=20 cough.
Duration of immunity 6 = months.
Leptospirosis 1.) There are=20 an average of 12 cases of Lepto annually in Texas.
2.) Side = effects are=20 common.
3.) The most commonly used vaccine contains the wrong = serovars.=20 (There is no
     cross-protection of = serovars)=20 There is a new vaccine with 2 new serovars.=20 Two
     vaccinations twice per year would = be=20 required for protection.)
4.) The risk of side effects = outweighs=20 benefits.
Lyme 1.) Vector=20 tick/reservoir relationship not in Texas
2.) 85% of cases are = in 9 New=20 England area States, Minnesota  and Wisconsin.
3.) There = is a=20 possible side effect of polyarthritis from the = vaccine.

Vaccines=20 Not Recommended For = Dogs
Distemper=20 & Parvo @ 6 weeks or = younger Not=20 recommended.
At this age, maternal antibodies form the = mothers milk=20 (colostrum) will neutralize the vaccine and only 30% for puppies = will be=20 protected. 100% will be exposed to the virus at the vet = clinic.
Corona Not=20 recommended.
1. Disease only affects dogs < 8 weeks of=20 age.
2. Corona is a rare disease, only 1 case reported in 7 yrs = at each=20 of  these Vet
    Schools: TAMU, Cornell, = Colo.St.,=20 U.Cal.@ Davis
3. Efficacy of vaccine questionable, IgA Mucosal=20 antibodies needed
Giardia Not=20 recommended
  1. Efficacy of Vaccine = unsubstantiated by=20 independent studies.
  2.  IgA mucosal = antibodies?=20 Immunity against a complex organism?
  = 3. Natural=20 infection does not provide immunity.=20
=
3Dbullet

Extra=20 vaccinations for Rottweilers at 20 weeks, etc-Are not = necessary if=20 high titer
Parvovirus vaccines are used.  =
=93Booster Vaccination=94 = before=20 breeding- does not increase = maternal=20 antibody transfer in =
 colostrum.

3Dbullet

Nosodes=20 =96 Study by Dr. Ron Schultz = demonstrated no=20 = efficacy.
3Dbullet

Not = recommended: Greene=92s=20 Infectious=20 = Diseases

3Dbullet

Distemper and Parvo=20 at 6 weeks =96 exposure to disease will be increased by visiting=20 a Veterinary
Hospital while only = 30% of=20 puppies will be protected, due to maternal antibody=20 interference with
vaccine. Vaccination by a breeder at = home with=20 Parvo only may help prevent losses but will delay
next=20 vaccination to 9 = weeks.

 

CritterAdvocacy.org is=20 dedicated to the education of pet owners
and  the = care-takers=20 that help them.=20

e-mail drbob@critteradvocacy.org
Copyright (c)=20 2003. Dr. Robert L. Rogers. All rights = reserved.

The Better Business Bureau. Education = Foundation
Torch Awards=20 for Excellence in Business Ethics
Presented to Dr. Bob = Rogers=20
for Public Education about New Vaccination=20 Recommendations
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.732 /=20 Virus Database: 486 - Release Date: 8/3/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.735 /=20 Virus Database: 489 - Release Date: 8/7/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.740 /=20 Virus Database: 494 - Release Date: 8/17/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.752 /=20 Virus Database: 503 - Release Date: 9/3/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.767 /=20 Virus Database: 514 - Release Date: 9/22/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.770 /=20 Virus Database: 517 - Release Date: 9/28/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.775 /=20 Virus Database: 522 - Release Date: 10/9/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.778 /=20 Virus Database: 525 - Release Date: 10/15/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.782 /=20 Virus Database: 528 - Release Date: 10/23/2004
 

---
Outgoing mail is certified Virus Free.
Checked by AVG = anti-virus system (http://www.grisoft.com).
Version: = 6.0.824 /=20 Virus Database: 562 - Release Date: 1/1/2005
------=_NextPart_001_012E_01C5CCC2.CCEF8C60-- ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/jpeg; name="Katy.jpg" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/Katy.jpg /9j/4AAQSkZJRgABAAEAyADIAAD//gAcQ3JlYXRlZCBieSBBY2N1U29mdCBDb3JwLgD/wAARCAEH Aa0DASEAAhEBAxEB/9sAhAAQCwwODAoQDg0OEhEQExgnGRgWFhgwIiQcJzkyOzo4Mjc2PkZZTD5C VUM2N05qT1VcX2RlZDxLbnZtYXVZYmRgARESEhgVGC4ZGS5gQDdAQGBgYGBgYGBgYGBgYGBgYGBg YGBgYGBgYGBgYGBgYGBgYGBgYGBgYGBgYGBgYGBgYGD/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQID BAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHB FVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2 d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna 4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1 EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ0 4SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeI iYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery 8/T19vf4+fr/2gAMAwEAAhEDEQA/AOxxS0ANaP0qPpwaAF2g9KOlAC7qdQAU6gAooAKWgApaAAUt ABRQAUtACUtABRQAUUgCigBDSUwEqNqAIiMiuevrVLfULc7Pl3EnH0qkBj6pbBoIfs+MZJx60/Wb X54QpHuPStEyhdMtYPlJYZPPWrwEPlo27AGc0MRDcmGG128kDHSucnkEkhwOKuIiEDcQvcmvRbCP ybRE9qmQFqiswHUUgClpgFFIAooAu02pAcKRkBoAiwVpc0ALgGjFAC06gAooAKWgBaKACigBaKAC igBaKACigAopAJS0AFJQA2mMKYEbVR1BQ1uWPamBykv+s0+EfjS6qUOoBUfO3ritUiixY2ipFnzO MfjU9xFGIsFwBtFAirqcsSwEZ69MVzzPuYlRwTVxESadH52oRJjvXoicCokA6lrMApc0AFOoASig AooAvUlSAU4UgDbUeMUAJtpMEUwE3EUeZQA7fS7hQAuaXNAC0ZoAKWgAooAKM0AFLmgApKAFpaQC UtABSUAJTaYERqCVA0bIehFAHF3Nn5esxqN23/61UbqH/TpyX9OldCGbVvajyD+99FqSW0XeyO3G RjmpEZurKBGq5XHPSsTeBHx2Oa0QDLS6e2uRLH1Fbkfie7XqEP4VluWkWI/FMn8Ua1ZTxSn8UJ/C lYOQnTxNan+Fh+FWE1+yb+PFIXKWF1azbpOn51Mt7bt0mT86QuUkE0Z6OtPDD1oELkUUAXweKKkA ooAUUuKQEZXFFMAK1GUoAZtpMUAFLlhQAu8inCSgB+aXNACUZIoAN1G6gA3UbqADdTt1AC0uaAFp aACikAlNpgRtULUAc/d2bjWfNB+QqfzxXNqmZpV/jZsc1rEo3be3MkGMhd1PaD1znJoEYmqKEWPf 0A6CsY4EZFaoRDH1qSsjVDqOlMoXNLuoAdupwlcdzQMeLuZekr/nUy6ndL/y3f8AOkFiwuuXi/8A LU/nUw8R3g7ilYnlR6J0NOrMxEooAKWgBaaRQA2loATFNIoAbiigBdoNJ5VADMMlPV6AH06gBmKN tABtpdtABijbQAdKXNADs06gBKWkAlJTAYahagClqMJltW29ccV5+fNil2nO7dzWsBm3Czxm3y52 cnrSvJnB+bp/OqEY2sOGlPHtWbJwmKvoBGrbaXzKyLuKJBShxQVcXeKdketMYtOpFBRTGLSUAev0 orE5haSkAtFMApaAEpuKAGuwRck8VjXniS0tW2/M30oAgh8WWTnDBl/Ktq3uIrlA0LZBotYCXFLQ A6mMlADOV+lPBoAdS5oAbI6xplyAPesa68SWVs+3cX/3aAsS2WvWl4wVXwfetQEGgB9GKAG4paAH UUAJRQA2omoAgkFcjrtsYr0TLVxAP3pz5gVdq8Co/NHnMnOOg9a0GYN0czEe9Vpj0WrewiKkrIYt FAxaKADNLuPrQAu8jvS+a1BVx3m0ed7UD5j2WlrEyHUmKAEpaYCUtACUlAGFqt0ZJfIQ/KPvVzt5 FC8oU1pEZBeWcZI8lDnFJbXd5pkigP8AL/dp7jO103UkvbdHHX0rQrIkdS0AFM2UAL0FVL28js4D I5oA4jVdcur4+WDtj9BxVWztvtaHnkVslYsZ5MkDl1zx6V1egavJMfJueo6UpEnSAinVkIKSgApa ACkzQA2mmgCCXArK1C3+0r2qkBmzW/8Az1PEjdvaq89ugTfvHHOfStBnPXOzz8L2FUZTl6uWwhtJ WYwooAWigAooAKKBhRQB7ZRWJIdKWgApKYBRQAlVryfyIS3egDkfto807jyx5rKuszXY2dTWyGbN sqtJ5T/8swOam+wRyDPc+tSAtvaS2Mm5W4robe4EqipYMsg0oOakQtBOKAKl3eJbxFmNcheM2pTk s/HbmqiNEH9lmJv3n3Ox7in6fB9lunVu9XcZK8PyOuakgARg3RhTJN7SbvzI9pOcHFa1YsB1FADT xSbxQBUudSit22MearnUkxnIFFgHxXysOGBFPkuxj5MUwM28nfH+sx9Kz4tRIcxTH8atABUSLjzP uDj8az9QZETyu/SqQzB3ffNUs81UwCioAKKQC0UwEpaACigAooA9sorIQUnSkAtJTAKKAENY+rsW ITtQgOWv7I+erA8VTsUY3Wf4lrcZsWsgjBdsc03+0JJZcR8L61AF+EvIu3zDRHO1rL1pDLTa2FXj FQL4gJ7LUWLUUXodYRl+YU8XRuEZk/CnYhqxz2qzSGT96eKZaxwTLw3ze1WgNCE4TyZeR2NQXUAV Q/8AdoEVtwGH3cGorg/M7JVAWNAu9t4V/hfg12MR4xWchEtNJwKkCqz7pcZ7VVmnjtxlnC/jQM5u 41GE3pd2DL2qtPqFtK2A5Fa2ArxXk1rPtR8oferlvqbeQ3mA4quUCrHeGWc4z+NMmuAb1BVWEX+I wGz8p61Q1CRHUNvHrQgMVjhcGoamW4woqQFooASloAKSgAooAWimB7bRWAgpKAE6U6gBlFMBG4FY OoSjzTQgOau7gtIYvyqe3QE7171sMbPCciFM4FXILUow4+WkM0Vj2oT+VZ18xxuqARk3GfLNFjE0 mf7oqkUX9rKdvatXTSyjZSEyDVoRIOnWsFree02yjgVSBG9Zy/aoA1WzHleelIk56XMJeL0olf8A 15C8daoCtYM0U+9f4DzXoEB+VTmpmIs5qKZ9v5VmBxl9q9xbzlwfl6Vh32r3F2drn8q1SGVMMaRo nXqtbCNTS4snLD5atu1qYSn8dSwM9h9li/2qoq2ZM96oC7JdEqkdQPHlNw/KiwFSc5xxUdZvcYlF SAUUAL0ooAKSkAtFMBaSgZ7WKdWJIUlABTelADqbTAhnOIzXJ6zP/pIC9KIjMXI+3Nu/CtGFcQLs rYDRlWOAbj0xSWd0s0nzVIFhiN2A1QyQfIeMj2pAUJrE/dq/Dp5itunPWgZH5P3VxWhHb7CrUhlH VbkDAWq29LmDDlKoRJpKqjsgrUK/JmgRhX64mWQDrwarQTRrO6P6mqGOkiUzB4vuyL+orqNIk3Wi DdmpkI0Q+OKp6vlbF2HUVmI8/cyXs3l54p02k+WA3mLXSBFI6wRqAozUNxcedVAPW+MVv5SdaS3k CfO/XtQA24maY9KjjjYHlaYDlicv904qxIPLiX+VAFIjLYqJhtbFRIBlFZjCloASloADwcUlABS0 ALSUAe1UVkIdS0gCkNMBtLQBSvn2RmuQuh5t0EqogVHs2Z9/Qdqvw7Ybcknp0qxkM0puWSME7RVl IoYU5nGaQyF79Yf4S3vVq31iE/4GgC95sDr8vpVNdVd7jb/DUgXWmjbBUcVHNdP5XFAGe373qKZ9 hb+AZ+lWBYtYWSdW5Hsa0Wk+VxUgzOul/fBOxrIER3yN+VUgL9rFiJP7uTU+k3Itgwzx3oEaEmuQ Re/0qrf69HLbOi/xVFgOb+0pD9xeagkld+S361ukBAQDUfyjtVCHgx4Hyil78Y+lMA+0Mv8ADj8K fHKp+9k0AW47mEcc05pIG9aQhYrOC4yEOGqCTT/nw2aQyG40wpHuTkVnkHOMVDQxtFSAUUALSUAF FAC0lAHtgxRishDelLmgB9JSAbUZbFMDC1W76nsOlYlp8zyTP16CqQya8Kp5aDtUEpxa8CqAzHlb PBxVdn/2jVljGvXA2AcU1XwNwyG9KBGzZTSNH3q5DYSxu2/pxUASXt55Uflx8DFYz6pj/WHPsKEM vafdxXDY+atXcYx+7PFBICckfPiopZtqt9KAGB/MEb1DDFuklTPFAiY7YkwDWb93JzxVAZ00ufuk 57rUHm/LzmrQxyzjuqmmfaB2QUxEe45pC3+z+IpiHB9sTJheab5bgZGce1AEZc9GopAITSiQigC5 BNJH8wGRWh9oEiBs802A6OXzRtwPwqheW+DkCkBnOu00ys2MKKQBRQAtJQAvSk60Ae1fdp4NZCFp m2kAnSnZpgFVrv5YGoA5G+kLTY7LT4YdqInpzVIoqTSq10y/lSMcxOnr0qwMlU38VOtkQvNMsz1c Wt6CyAhT0qzLOl5c/JFs3Gl1MzpLK3isbPzZT71csr6O9s3ZuD0pDOZ1JmEhX0rOilgW3kWVCZD0 NPoEiXSpGjlyn4101rKSelDGW5Ygy716+lUJlwfrSEUvMbPkjtzVlpdnT8aYCXJbo3GaglAFkfeg RgTN8+9aUESg8c+laCIj8vrSYLdKoAHy9aljZe/IoAla23JuhO4elQB2j+6fwoAhYg0zNQwH0UwL VpJtatCSH5d8Q/D/AAqwBBwHj6jtTLoO0XmY4pAZknzVDUSASioGFFABRQAUtAHtZFM5WsREgOaW gBKaVpgN6VR1OTFo1AHNxKJLn5u5qxOwVSR3qijF8svecDirFyFSJfoasDNXfHwF4p7XUijDfLRY oyrj5nyTViGRYlA28+1UhE7ahI1t5BPFWNMnIKx5+XqfegDVubMXkfmKvNc/fWJhl4Hy0kBY062b jpXRQQKu1t3NSxl2X5oqy7rGzdmkiTGWVhK/P1qyWXZ0yOtWBaucXA9MLVXVGC2ihSOlIDnj8pPp TOnIrQkkEmfvVIV7pVIBNu+oXXy2oYFiCU9Y/vUyTBBPemBXNNxWTAeo4p/3q0QC7dv0qxbXhhbY x+WgC75yk7eFz0ao4bll/dy9KAIbuONeY859KzyMGpkA2isxhRQAtFABS0Ae2UhFYiIvu08GmA+k pAJiqGqR5tGxTA5hMrdVLNxEv5UyiNIwqk1VkKtKuR8oqwEuMSZ8vArLuSgB/rTGjNkOe1NRjnrT EXRhkGRUkTdqoo0Y9QkscAc046jBdcEFGqLCH28JV/kPFaUMuflYUhlpD8u2s67XY2e1BJmxxbro /SrbokcMgHQDmmBB5i7xz0GKo3pVlCh/XNUIpeVulMa81C0ZXIIrQRF0qzb4JwxqYgXrmzMYEqfj THg+0wblHzjtVAUIsxyVK/OcU0BCy1H0GKhgOQ7afjmrQChzE3T8DUsgikXKZB9KQDYgfunpUjMe EPamATZzmqjCpYEdFZDFpKYBRSAWigD26isRCEVF92gBc0u6mAtRXC7oiKAOcu7Xy7xT2NNu4Q+E 7CgoZgC0JrOCb5MVYDLhf+WaDp1rHljaQk9hVFRK/kEmk8pomyRxQOwnmu3TpSxTGOQZqibm0tl5 7AZH40l5pDQpvTqKi5QljebsLg7q3bfEi89fWgRZ+4aztR+4wHWhEFC1kX7YnvUmphooZQo+9TGY UcxSTmojkk1rYkmhRkdJMHr1rS1K3UbJx91hQBkXEPlt7VCPlb2pgbmn3KvH5Mn4U4RG2n7bDSAo ajCqy+Yn3TVVTg1SAtRwLInFV3t8fj0oAaYGCbgOKcsZUZpgP+SR9pH5VOlg2M5GKQA8YhypFVZO OMcUAOjYOPLb8KgxtYqaQEbJt7imVkxhRSAKWgA7UlAHttOrIQU00AN6UuBQAzbjpTS3GMUAUbqN Sy1WkiAVmoGZkyFMQ9jVST5JhjOKpDGbfkx3NULqBUXPQ0y4ldEx1pZfmjIplmYfk4pEG5vequYn TRuvAPDVdW5Rk2ydKzZoY93b+RcCWFuK3LFt8Y3VRJa6cVj30m2Zs9DQiTHich8d88VpTzG4ttp7 VbAw5o9sntVpID5Pmjt1960JL9rsMfAGKllAMBT+D+VSIpvb+Zb4/wC+azDHsyDVIY0HY2QauJe7 4dr5oAZJJ+68uq+MrTAu2DjG09qLqIruj79VpANt7kR/I/3WqXgphelMCu8HpUq72QjcaAKcsr9C ajDNikBLDgt0pZwpXvmkBWIphqGMKKQBSr96kAmaMUwPac0uaxEPzRSAbTeVpgOFIVzQBXmj+XFV PLOfagZSukWN97VhO+SBVRGWYRuV2x9KzNTQAgZp9S4mXJJsON1Rea1UO4OpPb8qIf3TZ20yS1Jd s+GwMirUVzvbGKmxZfjt/Ng3fnWhYKVRlbtSJZcG3pXO69+6lx2pxIMlT8+RV/OMEECtGBWnAlXc McUaXP5bbTynpVkl4bYJ/l+4/SrN6ALdXTp0qRGdbyhW8o9KbfxfKJFFMZnsARxUJPPNUAmacv3d w6d6QAshjYMKuSXHmQo4PzpQBC6+adw6Vdgt3R8H7386Bj5E8tN0Z57rVTzhj0NCEVpOT1qPvQwN O2sWaDze1VZV2jbzmkBWYdqjqBh0oqQEpy9eKAEpaAPZ6SshBuxTt1AD80hoAi+5UgIIoAay7hio ZE2LlRQBz+qvtGDy5/SsEby3HSqRZsImyz/CoZbYDMrJkCgaOYkVS5zU0cStwBxVlEn2Xae9SyWv yqQKBEMqxogGP3lPsE826XHego6TT0WLzYm9qnYAdB3rMgjkbF0iD1rD8QNuuX9KtCMox/6PvXt1 qNLjZwa2JJ02eZx92o87ZeKoRftphcQeVJ94dKlilM9o8T9VqQMYyEHcOorYspUuIMfmvpQwKFzC LeUr2PSs6Qc0PYBoPano/lmpAeUJHFRYKnFUwNPTPKJZZOuKtfbg6AZGVpMZF5jNJ7N1qtcQYb7t AWJk0yZkzjip7awi+z75iBTuIsveQNZeREcdqrW9o14yoyHI71IzRfQUePrhvasW/wBEubTLY3p7 UriMwjFNxSGFFABRSA9j30ZJrIQYNG0g0wEyR3p3mHpSAQsaMsooAPO7GiRvk4NAGRc2fnZHfrWP dwtZqCEpoofDcBrRc/xNTkvQ0W11+VqGUjOuLSN+YsYAqnFC28dvpVjL6W+Yt+/NQXF0Il2AUEoq RI1zJnsK19It/LZpKGUXQfmqaP5YfmNQAydlW53/AN0Vh3EZeZkc9+KuJJAyrFGVLD8ayZMGtUSW YcPEFBqI5381Yi/p+1mYd6shNt1kfdYc1LAyZE+WRh6imwytbzB0OCKoCe+k349O1UHPNSBHT6lA SrJ5eMUjPlulXcB6ZGHHTvWiIYHVTCd1SyieK09TgVPGiRPskKtUgJeXuwGPafwrPiLXGI030wNa 08Ns5DSPtHtXSW1jHbrhVH1NS2SSeRntUUltkYxxUgYWp+H0lBaFdj+3SuYuNOuLckPG31xVgVMY oxSGJS0DPZWhFGChrEkcCDSkUAMIC1HlaYDeKcH7ZpgPIBFU5D5R20gKE2qJb53KfwrD1C9uLwAJ C2O2BTSGVYWmjGyWMjv0qaCUfYx9TimyxIhvcIpx61p21sol29e1AmVt0du8iEcVTmSG6+QDHpVE lmC28r93jnHNTmaO2iC559KllIijutz4Hfp7VLPPuVEU8VJRUvrgY2g855rKvpzLHHKDh+9aJEmf JMz9aj7VZBLC/ltVgjeu/uKsBIpvLyatwXWYyW7DFAFXcEiKZ4NV5OKYCE5wKjIqWAu3tiniB/7p pAaVjo012n+rYHtxWlB4UcHM7/lSuBS1HRZrJh5O5kNVIreeNhiNx+FA7l50u2TlTj2p8Wj3UoDL wPekO5oJo0vkYlKlqv2OmR23OATSJNJAoqTA/vVIC4I6GjeR1FIBp2mo5baKQYKj8qYGLqPhqGcZ iwhrnrvw/eW+fk3j/ZqgMyWB4vvoV+oqLpQUe34ppWsSSJo+aZ89ACFS1HlUwHNGMVXkh9KAGZZK oXjy7vlXNMEOgsFkw8y/hV9bOPsgoAZJp8T8FB+Vc5q+hmCJntm+7zt9aBo59Xk3b9pUj1rXhvjF t9auxQlyn7ssxqljZKDngUySyt0zFmyarzqxj3PxSKKiStEd24Crcl0kVqsn5U2hmRJcHzyQeKdc Y2j6ZqkQQgL5Y/vZoYYqhCrHmpTjZ71QFelzjgVAAFZu1WotOurgjETflQBuWnhlPLBnkbPoKup4 ctcY2mpuBoW2jWSDHkrn3q0NKtcg+Uv5VNxFsRInCgUFakCvNCHXpUf2VCPuj8qYw+yJ/dFSpFt4 oAl8vcKYExSAdspcdqAF2+lJzQA3atBTjigBvSkOD2oAp3NlBcJteIflXLX3huZJv9G+ZDVAenZp ayASmEUAJjFFADGNRFsUwI2dai2A0wHodvBqyOnFIBTnFZerzpBaszUAcfNKn2Nhxv8AU1QiLBuv zGtkUTSSyyYT5sD1p7XKRxbNuTQMq+cfTipJL0yR4I9/pTAz5NzsSBxRJIWjVP7tBJFTt3yUIQo9 qfVgK7hn3KMfSmZoAdFE0rBFBrodO0AMf34zUAb0OkwQj5Yk/KrsUaRjGwflUXETDZ6Cn4GOKkYz YVNP3e9AC06kAymqOdtADtuKXbTAXpQVzSAavXBpxXFMAGBS8e1IBNu6k2kUAG32pm3HPagBuyom jpgaMU2+MNUoY1AC72Ham729KADf7U3zKAI85pu3caoA8iojC4oAicuDirMEvy0ASNJxXO6pKtxL 5A5oQGJJp+bsD5sfpUR0x3mzujX6mruWWorUocSSx/hVyK305exkalcLGdqWnBG3Ipx6Vm/ZvmG/ IX2ppjJPNW3Ui3Vf+BCqEjbmLeXj6dKoRHsOOlAjNMksi0PkeajBvbuKt2OhXF1z91fei4jXt/Ca k/vZD+FW18M2sf8ADn61PMBct9Kt42yI1/AVoLEqipAlC0/bUgGylXigCQKKaYs9qQDTEV6UnNMB zLxUL8YNAEuMil24oATFOoEMdaVW9aBike1N8ugBNpWkzQA7PakxQAvGKNooAlt1ULirYAqQDbSb aAE20zZQAnlUmzFAC4pMUARume1V2h5ytMCG58zbhajFskUe91XPrVAZk53yZ3KKzbrCNzn8Kk1R ReX0FTac+JMyHj2plWLd1eCZv3Y+SpbezSbCd/ekIhu9KVY+OvtWYNOl8wLs5+lWmI0LzSgsSYz0 5qtZaX5ykFvwp3JNq00SKDBJJ9q2FhUKNoApEEwFPwKQDdgFO2+lACgUvSkA+mkUAKDin7qQC7s0 YoAQj5agdfloAIjxUlMBcUdKAFxTGSkA7qKXB9aAFppQelAEbR+lJzTAKdQBJEMVZFSAuadmgAxS YoAKTFACYoxQA0rTStAEbR9qry2vmKV5xTAqppKCTcc0TaRBKuNtA7lO50CMr+74NZ8WmNBcDzRl PagtSLsFh+4EXlDFWrfTNj72Y0CciSSyG5aEtURicc0yRXgDriq1rpvlTM3rVCNLy+KRV28UgJQt Jtx0pAFKKAFp+AaQC7abQAbaTFAC0+gAPPFNZc0AQAbGxU9MBKKAJKTHNIA20m3NADBkU7NADuDS YHpQAzy6bQBTtL5FURyuNw461pxyZoYEu6l3UgFzS5oAdSUAHSkxQAmKTFABikxQA3bS7RQA0rVa aMdcUwBMYp/SgBOtMK/LQAiLmpAmKYDwKYyYpAC0/FADStIOKAHYoxtoAcDTaAAU7FACbaXpQAo6 07FICKSPikT0pgPxSYxQAooNADqTFIBdgpCgoAZsxTsUwHimFRSAzbvR4bmTecg+1QCyvLTmGTzB 6GmBKmo3C8SWz/gKsx6ipOGV1+tAWLiSqw+8KlzSAdS0AFJQAtJQAUYoAKKAG4qGYfLQA3tSUwCj HFADVGKkBoAdS0gIiMVIOaYBimMtACrTsUgDbSUANp2KYCilpAOHApaAEqMpQAU7HFADcEUtMB2O KTHFIBuD1zSg9qYB3oxSAcOKKAG0YzQAu0elI0Ct1AoAh+wx54yPpUoUx/SgCUNT6ACigAooAKWg ApKAI3fbUHLdaAH4oxTANtDCgBMUtAC0tIBMZpo+U0wH5p2OKQERG2nqaAH00igBMUvSgBBTqAFp aAEpKAG4pc0AOpMUAHakoAO1NxQAEUZNMBaKQABTqAFpaAFooATYKTaVoAXmj8KACigBelJuNABz Rt96ADZSYoASjFAC4puKAExSHrQA6loATFGKAFxTsUAIRUeMUASUUAJiloAbjmnUAFOoASkoASmE UANV8HFS5oAbmmimA7oKZnBpAG6jIpgIGxxTs0ASUtIBaKAHUUALS0AFFABSUAJRQAUUAFJQAmKO 1ABTaACjFABilxQAtJigBOhp9ABTCKAEFLQA/tTCaAF6U2gB1LmgBuaWgBtJQBE9PU8UwENLQA6o 2SgBMYplMA6UcnpQBZFOqQFpaAFooAKWgAooASigAooAWkoASigAooASm0ALiloAWigAooATFLQA U2gApMUALTaABjhaavrQA7dRmgBM0tADe9NJoATtTRxTAM5NSigB9NIpANpuOaYC7aMUAf/Z ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="sumhorsa.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_themes/sumipntg/sumhorsa.gif R0lGODlhWAIKAHcAACH/C01TT0ZGSUNFOS4wDQAAAAFzUkdCAK7OHOkAIf8LTVNPRkZJQ0U5LjAY AAAADG1zT1BNU09GRklDRTkuMCAk+fVyACH/C01TT0ZGSUNFOS4wGAAAAAxjbVBQSkNtcDA3MTIC GAEJCfKRoAAh+QQBAAAAACwAAAAAWAIKAITAwMD39//39/fv7/fn5/fn5+/e3u/e3ufW1u/W1ufO zufGxufGxt69vd61td61tdatrdalpdalpc6cnM4AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAF/yAgjmRpnmiqrmzrvnAsz3Rt33iu73zv/8CgcEgsGo/IpHLJbDqfUFxgQB3gBgfD IbHdJhQJg6FQCAim50H6HG273/C4fE5PmQf3/Jks/ia4gFkHVjdVeAsNiAwOjI2NE5CRkYwQlZYQ Dw2Zmg+dnQ0NlRKilg+VDgwLCnysVGwnAWiyagRjBba4rLesCr2+vw0OCmKvTlNVdcnKy4YBUGZi Cg4Nv9WrubvZ2AYEAnjeec6w3gPaZAoLi5WmpBCjEKCenvGal5aMkvmO+wyJiemgQtmzlE9SBEsH E1rSFE9eJ3cSJESQMGHiRIkUIWWENLFSwI+cGD0QSfLjNJAoU/85cChv3cl+phKJEefjWLN+ivY5 KhgJZUAEYoIGNURUHM0XoIQiUJAq1YIHC9IhmurPATxQVBEBITqgloEEBLiKHVvlqAujZIUq9QmK JySdjXA2YGCzLJAAYhBhmgtq5TqWnRwAZBvwZN+RK0mu3IRSVARJGzFifCx5FGB6CCEorPTY7cCF oFKJIAAUaFOpTd1OyDTwoL2Hfy9i1HiR8gSKEW9HcP0Zk6mH8oIJZ+yzKRgFwilhWo4wt8VTcPdB kAQh+j5/VBEMFvhZdW9408ILx04+mIMJ1q03ABp06emnUVORR2Q1YFbzjqBXt0qpP///jswXUHUC 3mcgeelFh97/SQcm5+B33vUWUCoICJggJdRdaJVmEt0m0SW/QSfccU0RxpB4LQHHTm+74YbbbRVF NBFtEUkEm2+tDaSJaqf1aEBpBOxA1i1KAcUUaun085lVGjWpm0f3iTReSqhZ48cwYhRAGn0ramaJ RC16+M53olBH5kL9fDQMe0AlgGRTDKgmoCZS1TnlR+xMcOZnmaRp4p/UzGUYKHsW+hlIqAQK6J8w GXqJnnuhNE18lG5yH489ShUGmwYg95GShUJWaI26tZhZKZMiQACRnV5ZTY9sTYOYgJxlZCsk1R3K QKYMrMleUAWQtQwRZHVlQFddhaXGskSd4axZJnjzYwIIUPsHkjo3jtTnm0g+JUkivCL5qxgIEFLD kKtqSQYfav3YaSoS7MptuKqM2+69aiGwVLrjulcnVHU6JTClVfZLBgEK6IvvwvmiM++8DEiQzpr3 rquuusLaMIC92oV7WgOSAOwxQNqWAhUY1lYLlBormOEyOYZ4Qw4BYYXFTbHD5qzzzjz37PPPQAct 9NBEF2300UgnPUIIADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Are We Over Vaccinating Our Pets.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Are We Over Vaccinating Our Pets.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5y0ASNo Phs/AVZJ54lks50oeDmtCMfyDJ8vjef6Tt/8DwwmfApAJ8UBhTiBY7OpJJ2QqehzkZEqr0xEtmul Mp0e4lCITvPMCLb6DX+4DfO4/V6/fD3VKb+05TXC1fcnWAJ1tJTIF8i4leUY4ufgR8aFCNi1KcWJ OQi29+QkujdpOIphI3fX6tomByA7S1tre4ubq7vL2+v7ixsLPExcbHwMzPq6bJfH/PzmDD0d5CwK QbqJpV1BGaRSyV2UqorYSV56OLbeqECWjfoFj054tdiUF4WUKZgN/ikGIIN0qPilg3fQUx1LXu4Z TALOUaZA/wCaWkSxHpQaUfJC1ZNGLaQGiXSUiTw5AyTKlRXqsHyJowAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Are Vaccines Dangerous.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Are Vaccines Dangerous.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5y0gSNq RlvXJITdRzri5aDlyraga8HyTNeUaud6ji9XtwGKRobMaBggKpOYJNKpOBZFzGKVOTQ2rcDpq6cA 78ZkkhhxLqvXjLTBzY6v4Sgtd0q8CveYEJeK17e0BfgEFeSHFai3yPEAsNRlFeV42NRlp3g3yRnk hfl5uaXpJ3lAJ5eqGkAH4PoKGys7S1tre4ubq7tL+8j7CxwsPPz7uHo8Z4y8vIPK/FzjnBkxGGd6 fO2zCcVYWQW6rQWueVWeef6NnjiOjoGa1WnSTc4ZXu5dry66HW8/ykQnEodElAam40MOEUJBR8QR slNooJCDjpxBU2OIh7IOixxZWOwIsgKckCRdFAAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Vaccination Concerns.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Vaccination Concerns.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5y0gSdS rmFj403CyJXS5aDmyrbupL7yTNdRbOe6jSv9kgmNSKGOxggCDZHBQzPpVHiexuKQGIWSHj9EdwcO V74GsviM9nHT7PbCbEbKl8rpNkjvELH6zfUodZc3eFdFWKSWIiGkNOdI9cQH6Ygw9RhlmZlVtfm2 5gbaBgdAWmp6ipqqusra6voKG6vKJVtre4ubW/sZ2isG5xsMBixcXEPcYLWDuNjpi5ycpZmkOc15 jc0ImH1J7YfpnAAdbUm9bY5+PVkOVQme3t7OLscwHl0ZudWX7tckWRivjhOATPTRYdePmRdexhq2 sOcwIgWIEisytIixRgEAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="New Vaccination Protocols.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/New Vaccination Protocols.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5y0CXSr yYdTb22fQELg5AGPqrXuC8cHK9f2jbd0zve+sVtkLkRSKUBEKhXJjnHZSTSXxub0inlCOdYoiEsV BBXjn/msW6HXbEoZ8W7L5XHRcHMEizBRPPeIlBcI+FTo5/flFVY0ROh4N/jwt9UHxcQXSAmG1Uil WWlJabentKmYAXACN8faGlD3CiA7S1tre4ubq7vL2+v7i7sCPExcbHw8rOa6vAYLywwd4xxNzQNL 6JLoo2oCKpS96tBlWkpKClk+Okqezgm6id6lnl6Oyr2XdJIfOs9uTu8OoKh/etopwkSPnxRMWs6F yLLIyR09JYpEHBjKg5YZPI8k4gPE4Fm1kRKmkTz5wiTKlW5YuvxRAAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Immunology New Developments.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Immunology New Developments.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL5jI+py+0Po5y0gSpQ rkb4zQVg+Izk5aDkypbte6jwTNd2JN/6fueK7xIJP57OUKhJEjcZJvFoBDWNw6cUKTJJgAgu7wuu eA3jsPn8e5TRbHN5nZgiP1Ts6N4p2vNMfrT/5JdVRDfI8YZxQKjIWNc493gVtacnB8h41eeIo9bm +RnwBjBKWmp6ipqqusra6voKm6oWS1tre4tL2wnK67bbC7yDGExsMzyhh5W4icyjdfgrYUk5qYyX iZmdCTiNXS05cSw9qTUl9wiltHnODpled84MIR6BZxipECjoWOjETaWpHyZ/0FIUm/HsE72DDEMs bAhxS8SJYAoAADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="K9 Recommendations.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/K9 Recommendations.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5y0AShQ DqKnDlZitX1GOTKXs6buC8dTK9f2jUd0zvf5rgAqPChQ8XQwZlCcZPO5RDaVz6mTE9pEkSUt0/IQ +sZkkfhwLqvXi3TAzY6r3XDttYr3dj0n/jI0BYiltwdFRNRHmMQX1vjQJZV3BUnpZGcFVbWFiYiV Wcl1B8YiV2r6Fgagusra6voKGys7S1trewubirvL2+v7i+t4OlxGR3w8Zoy8jKPsAKmpIc38hdcs 3PB3V2QUufntadcJDtrJGQ1q3YbNAD3tHRmPLrUlbhKKf55+BOGcPS0onp5Fey7ZyzQIXrg+gQxd cqiDHbOJLvxRvGhGIsYHjf04evRRAAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Feline Recommendations.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Feline Recommendations.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5y0gSRy XiL0qW3VSH2YYZKXs5LuC8duK9f2jY90zvd+sFPsUp6Q52jqhFKfpJGYPEqVqOpSijw0NVMstVoU PoK/slk1PqvXFDLCzY7H4Yahgps1okRaxNYJaIWnhFf05zS1wfW3x1dYl+Z3YpVFCXbZ1Be1CfaV yWmpuNcFWokFFCmnqkoHBPAKGys7S1tre4ubq7vLWzvWCxwsPEwMnLqKrNbamtxcs+wc7QMt6UAU wSR9WR1DrTWoafp1euVlvukZ9hkeOp5e6v52fEpPVTrZxY2Zn266D0+KHbkE3rY1ohTFEL5EgQ7y e6jQnLpRhBjui3igoLYRjTA0cvxYwSPIkRCYkTz5ogAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Conclusions.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Conclusions.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALLjI+py+0Po5y0gYqN 2DmI+HWic5HjiabqUq7uC8dIK9d2SrN3iPCf70n8DiGOJngEeni1nMJ5i0oj0Nn0ijVps1xu9fBV MYnGjXFZRCLNR7SG/R7DwgF6CognqofFYXIPqCRDZ9dl6EIIoLjI2Oj4CBkpOUlZaXkJ+YC5ydnp +cmpeTgaRUh6OiiKurpiuqOHIcdqoVojl/f3hxvkx6snGONqq7Dbm6u2Fgjb1lRrA+cGGN23VhbH 3CeL6DzbjSHsHT4BLl6+ZY6uUgAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="References.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/References.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALMjI+py+0Po5y0gYqD 2NuJDIbT5ZDiiaZqYq7uC8dHK9c2Sis5/GkH1/FpgMIhp/jp/YjDm2GHgDqnVIb0Wc1qF9dAdwuO db8opfBoNKCT6iAz3VaibWOnXP3DI/f4uz9/R/dAFlaYMgaQqLjI2Oj4CBkpOUlZafk4eKm5ydnp qTloKCpYMmoKU3eqehh6Y2aGALuakWoD1BOIC6jbB+jbq1dTW5OrwJsXHMwWyyCL2mrLDIfkFlut N5cdRGox6w0y/C0OET5uznWevlIAADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="The Science Has Been Done.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/The Science Has Been Done.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5w0iXuD mHgvXzWgRnVjqGET8LDoC8cy7M72jedorff+b+BZAizQxvTxnI4dkuFoaR5GSlVKQU2pkEZEtguW JoTAsvlFHp/XbEoa8W7L5fFN8frMeJPKfFWvNQX4tBfoNzR1qChGmGgoBWC1d0fY5ViZCIW5SWLZ uJnh6cSp2Xk52keKuhA352rWSgQwS1tre4ubq7vL2+v7C5zbEkxcbHyMTNzyyky33AwN+xxN3VNH NPqQZbYt0Y0i6nBd1Bc+CLaKrirYpJ5tUhq/eirvvoTt7lDK+bmfXbjuk0B/9wbusfdv0jxJ7Izo +dNPkSF6eZww1AJIkhUaUYw2Joo0CE61kTlixSKJMoLJlCzRtHxppgAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Canine Vaccination Guidlines.htm_cmp_Watermar000_vbtn_p.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Canine Vaccination Guidlines.htm_cmp_Watermar000_vbtn_p.gif R0lGODlhjAAZAKEAACeNjQAAAP///wAAACH5BAEAAAIALAAAAACMABkAQAL+lI+py+0Po5xUhQti oBv1+jldKF2kl2wqlDltBcfyTDNvjef6Xt/8DwwmfIJQy7QyrD4qpKXoMUFRKKZSOppCrQfmRbvs bsFFZOa7IArXbJoa8W7L54+4wU7P64nG60i6BVh2wjXYhWYYiIj19edIAkn2N9a0+HW2KDZplTSm tBCyqTnKeTXViZoidhpWRjmqBFB4gKdn24YHoLvL2+v7CxwsPExcbHwcXIe8zNzs/Lxcdzt9m0t9 TWeNvb2mNqsTKXRSsgrRKa1KK0kKq/X5XvpZGu+ZOjs+b9rqWSTbLnCm3b5zTwoRjEQvib1y7vgN fCUPDkMTRx6mSvQkCiskL1m4NHLl6F1DjCBZvfJ4iaQ6bix/aGsJE8fLmDRj1KqJM0cBADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Feline Vaccination Guidlines.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Feline Vaccination Guidlines.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5x0iXtt EJQjX4GOJ0pYU3KqBDxtBcfyTDdvjef6jt/8DwwqfAnODZNZgVRIxerQTBU3UEPUSsUuP9Bk9UlV fpubUoIoTKtr6PP6DY+1EfO4/W6oGz+ZcLn/51RlBXhCSPK3lOQVmDjFtUUixlRYaUZ19OWnNfiI VZa16RdJmAV26okI+uSFGvlyGVCHR7s2KwuQq7vL2+v7CxwsPExcbPzrcqy8zNzsrOxSK313ezt9 nVONvS2kJ4sCIyUUC7EVARahZ0jq2vlpqsnJSSrf/h7KNV8qJh8GK5gJUih0gsyJuifKnj18Uthp WnigxaU9XRChaiSIjykjS/0khWHVx2BFjSBHDTw0koE1biwpaGsJk020mDTl1Ly5pgAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="FAQ's.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/FAQ's.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAKwjI+py+0Po5y0gYql 2BsJxR1fRk6Xc5bqyraoC8fy/KT0jcf2sufO6BEZgEMP0QfpJZTIptNSe0qnvCj1OmUetNJjEXj8 jELYpbVcDKrB6oD3yg3E0fRVHIDP6/f8vv8PGCg4SFj4V2OYqLjI2Jh4VhcJcydZ6UJpmVmCSfcm 1jamKQdZxkH0mSaU+kbFieZlGuqG2kbnWpoQJmJqxNpKKhoMbCZcPIwwZxycrNwMUQAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Library.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Library.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAK1jI+py+0Po5y0gYqh SHvnDzqXGJYm453hqLbuC1vxTMcsc9dNanSH/xMIAzyg7pFTJI/MJunpjEoTS0R1iq1dDVsmjwge hntiX+o77XaP347H+Db2slQk/X5UA/b8vv8PGCg4SFhoeIgYiJTI2Oj4CMloh0dpM1mJqaKWyWmy eYcG1lnxSddG9IY6N1f2g1eadXomSisnlwWLJbQ71ho0hhCadjmaITwMVawckbvsvLD2LD1RAAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Web Links.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Web Links.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALJjI+py+0Po5y0gYqZ QDt19RnhMWYmcjnpybbuq8LyTNfPauf6jC/9vvkEA4JikUjieJAiYui4U/wS06j1CqketNiuN8AF f8dkcQzbGTKNTWhSaUw3naVdOEwbydv7eVKI1FeXc1dmiHUHoLjI2Oj4CBkpOUlZaXkJeYO5ydnp +bl5czhqJ0p6SlOIuvqi6qXGpLQwuDTqaiWX+9cX2/a39nZ1GwU7pBfcG/h73DVMXEvH5xGn7Lvm JmzKum3izP2dpQ0+Lk5u/lIAADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Consumer Warnings.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Consumer Warnings.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL2jI+py+0Po5y0gSpy 3U8gf4CSyD2Xc5bqymJq2sbyTG9wjed6cCt9QzKIPENhURgAKZMZTTAJRSqb0SrRimVWfgju7gve msLkMsVrQJvXZbX6s6AyNcaldD6kX0P3qPzatBQYsicn4UZRpMi3qGW3B/VUheQHudjoxHc4xtbp 6QYQKjpKWmp6ipqqusra6npq8io7S1trK8vpqduWu+u7g/grnBM8ounZOOlbDPGUbImVGckYJNgX aTeNCb2JMuHMeOwXPl6tAI1+DEg+KWnRG2H4pym/Pj5HmWBuNJ1vX1nJHQNmw4QNegGvoEKE3hY6 ZPgwIpgCADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="To File A Compalint.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/To File A Compalint.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL7jI+py+0Po5y0gWqE 1m5zEYCQuGwYQqLleTntCcdyOGNvjef6bvP+D0zcFkMK6ahSgTwpWibRdNJEVOkyY7o+o5GiMAgO 47wIsviMZpgN67Qb3W53UJzkQWtSaO30qmdbFVK3lFVHEReD9HQHNcX4CLnouLVISEl1hcQFgfjm +RkHIDpKWmp6ipqqusra6vqK+gA7S1tre0sr+7nr1sn7C+YLPMwjXLHJF8mwZ4c8MuFsoQujKCU4 OGlN2cg9hSd4ybjHPGFsBJnSlNnA1I3u5CdulU0uYQ7d5z6ZpxzFnxcoU8B1mqIRmUYMjMFiCBM6 nHHvocRyEyueKQAAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="History of Dr. Rogers Efforts.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/History of Dr. Rogers Efforts.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALxjI+py+0Po5y0gaoE 0jrj1xnCOB5hyKCfcjntCjtqTNNvjef6jt38DwwGfCwaiiM6iUyBYzOhfG48S+kz2pz1HkSh9/vp IsTgsplBNqTPbPN6DXF2SNl56WpV0evTTWkPWGenRfFmNIW0NMekRyXVCMWUN0m5YtiGmfkGwNnp +QkaKjpKWmp6ipoqyqXa6voKG9vKlVnLdmmb64Wr28vD++GUsgPZZ9VACAOMQUKXiDd5h0Wp11z1 yLhYGUYbI9enDa0YWVUsiT1+rc7tcsiYZAe/rrV3LBh+Im0yaNPta/+PnYWABGssK4hQApyEDGkU AAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Thanks To.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Thanks To.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALEjI+py+0Po5y0gYqP 2DuI+kFcl5XK5aDmyrZu+sbyTD9qjefyvfC6pwl6OEDDh2QMKZTMX8L3dEqnFCjCSs1msQau9qvz emdNJHFICqmRCCXaOBVnm/B1EXiE69vCu1QOFkglBlBoeIiYqLjI2Oj4CBkpuWgzaXmJmalpaSPo 6QT4KUoTOmrqUupEN+H20AqW+sOkdpdXV7TalwvaSbVqixcEvMe39xrWO/WbFHyLy9b35ocMc2rN EnutLZG97W3xHV5TAAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Help Us Help Our Pets.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Help Us Help Our Pets.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQAL+jI+py+0Po5y0gSdQ Vpv18HHaEpJC6ZynVwWX87aiLKP0DcX4zvf+7wIKh0TLQ0caqVaZzudpWCWgyyboAFVir1NVdMkF 2RJIRbmITuPOCLb6DT/K4/S6EYYZiTdW6fbvpRf1xXflN6g1aPXH5RUYiBfZQLXVVMhoiEmpKIbI eMk089mIueBmcGqnmpYK4PoKGys7S1tre4ubq7tbe8T7CxwsPPw7t3oc14q8/KbM/EzkPClILRqW VOrJop3H7Z1j7FEV1nepvXhdhV5+PkXeKbhO+t0Wjs2ZmE4dslmp6e7kGjd+7uyZ6YbokaESYAgV TCiFHYdDoRhO5INxzAEWaTs0CvEIjSO0kTxEkjwpIxXKlUAKAAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Memorials.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Memorials.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALBjI+py+0Po5y0gYqT 0Flt34XJ5ZDiiabquLbuCytmTNfpvOD2xge8AOz5DMLhZ+gLIoG23EPXjEpLz6n16qRit1cowhtj Ej9KYzlJNo7T6G51yi4K00f5sle3gg17rr/VByA4SFhoeIiYqLjI2Oj4mPgEOUlZaXk5+fa3GRPI +fniCTp6oxkllkRztCUqhadGlEp38BObZzfVeqpWFLuEBBvcuxql2xS35hsnlid7R9xkTDpdIU19 DWGNvZ3F7b1SAAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="donation_form.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/donation_form.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALYjI+py+0Po5y0gRqF Fvjw8Emb1pXM5aDmyrZu+sbyTD9qjefyvfBuCAoaOKHPSEj0CJfMZXIIbbZ8Caruip1YD9us94vo BsTg8lVMxgCNJNDGQ3qz50DpO5g8ztC0YhSvxIbkRKiE4Oc3uGNj1miGBhApOUlZaXmJmam5ydnp eWnzKTpKWmoqyuiomsW36prT+iq7CDOTqNZRtxobs0aIGAgF/OfWhihotJcq4zsMKAwdzVTnnCzF wvuiN2RsGOeG1E2se5doHZM9q26Svu5O0f4uvzxfT1MAADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Slide Presentation.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Slide Presentation.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALtjI+py+0Po5y0gZqE FoZz9DFbiDUk2JXS5bDqC8fy5M72jedRrfe+zlMEMZqU5+AZgTapjjJQdDJDR2m1Cs02S0NE9wcO V74GsviMFj7M6fbZzDYprvQTNfthSpFRpX5alNenpwL3QnJEp7XIuHj3iOSoJTgpeVe45qa5GQAH 8AkaKjpKWmp6ipqquspautYKGys7SwubyYn7dpvL62PYC5zzW4LYuLVweXMSGTZMXKyYbJkXCWlU vXVlycy1G5O4jZzBPd5ofR5uTONN9DdZV05OON9XTZn0Tn08xh7s/+Lsn0AMAQca3HEw4Y8CADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="The Poem.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/The Poem.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALAjI+py+0Po5y0gYqV 2DsIyX3ZSF6OSabqyp7tC8fyg872DdeLjiOid/iEfh6O4ScMAZfEXoCXgDqnVAutis3urtpuVnoA 45DFYMcXPJ6LouSaKn52ycel/W4Xptv1ajzuFfjyB1BoeIiYqLjI2Oj4CBkpuUgzaXmJmalpySXo afP3KSoTOmrKUppFB7F6GtWJhcTXSla7p4fXkxqbVtfUC4zby+cHW7Xa9pZrpEZMDGfsKj2xO20N UX2tvbXd3VIAADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Finding The Courage To Change.htm_cmp_Watermar000_vbtn.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_derived/Finding The Courage To Change.htm_cmp_Watermar000_vbtn.gif R0lGODlhjAAZAKEAAMzM/////wAAAAAAACH5BAEAAAEALAAAAACMABkAQALrjI+py+0Po5y0gZqE 1lLk5T3hNGLm5aDmyrbuqr7yTNdYbOf6HuCKTykFRh7hoXjcIIfK4dFpCDWJ0Q0UynEBEVue91vp GsTgsvn3IJ/XZbLaYbQ6hdRqMStH3rNM6dxuR8QHk9ZC92T0pPh3tcTIyEEl5UjZ4saGmdmTBtDp +QkaKjpKWmp6ipqqOsq56voKGyu7Wqhp21Z7q7tzuetr07uSKPKhMPwbEWzS1MhkrCgZhegXLY3X XH11krtc/PhRB+1dmU2+qL2dYmh8zUCHN+lnDa1H/xivxY28T6jO/5/OAsCBFN4QPIihAAA7 ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="sumbul1a.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/_themes/sumipntg/sumbul1a.gif R0lGODlhDwAPAHcAACH/C01TT0ZGSUNFOS4wDQAAAAFzUkdCAK7OHOkAIf8LTVNPRkZJQ0U5LjAY AAAADG1zT1BNU09GRklDRTkuMBuV8hxWACH/C01TT0ZGSUNFOS4wGAAAAAxjbVBQSkNtcDA3MTIC AAIBPjG4mQAh+QQBAAACACwAAAAADwAPAIS9xs69xsbAwMDO1tbGzs6ttb21vb3GxsalpaW1vbWl ra3OztbOxt7Ozt61vcattbXGxtbGztalta2tvb21xsaltbXe3ufW1ufe1ufWzt7n3u8BAgMBAgMB AgMBAgMBAgMFW6AgjmRpCkMEBIaEJGVDAOuTKO+ILRC0JrbSjgEJUB4Bk4bBUBUMh1Om0YA4DEkl o7EAFCYnwWWxdTwM4Uwv4qigT5geoaCIniy0gKQeFmQKFQowfSgEA4SIJCEAOw== ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/jpeg; name="bbb75.jpg" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/images/bbb75.jpg /9j/4AAQSkZJRgABAgEAFAAUAAD/7RG0UGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAAFAAAAAEA AQAUAAAAAQABOEJJTQPzAAAAAAAIAAAAAAAAAAE4QklNBAoAAAAAAAEAADhCSU0nEAAAAAAACgAB AAAAAAAAAAI4QklNA/UAAAAAAEgAL2ZmAAEAbGZmAAYAAAAAAAEAL2ZmAAEAoZmaAAYAAAAAAAEA MgAAAAEAWgAAAAYAAAAAAAEANQAAAAEALQAAAAYAAAAAAAE4QklNBBQAAAAAAAQAAAABOEJJTQQM AAAAABDLAAAAAQAAAIAAAABgAAABgAAAkAAAABCvABgAAf/Y/+AAEEpGSUYAAQIBAEgASAAA//4A J0ZpbGUgd3JpdHRlbiBieSBBZG9iZSBQaG90b3Nob3CoIDQuMAD/7gAOQWRvYmUAZIAAAAAB/9sA hAAMCAgICQgMCQkMEQsKCxEVDwwMDxUYExMVExMYEQwMDAwMDBEMDAwMDAwMDAwMDAwMDAwMDAwM DAwMDAwMDAwMAQ0LCw0ODRAODhAUDg4OFBQODg4OFBEMDAwMDBERDAwMDAwMEQwMDAwMDAwMDAwM DAwMDAwMDAwMDAwMDAwMDAz/wAARCABgAIADASIAAhEBAxEB/90ABAAI/8QBPwAAAQUBAQEBAQEA AAAAAAAAAwABAgQFBgcICQoLAQABBQEBAQEBAQAAAAAAAAABAAIDBAUGBwgJCgsQAAEEAQMCBAIF BwYIBQMMMwEAAhEDBCESMQVBUWETInGBMgYUkaGxQiMkFVLBYjM0coLRQwclklPw4fFjczUWorKD JkSTVGRFwqN0NhfSVeJl8rOEw9N14/NGJ5SkhbSVxNTk9KW1xdXl9VZmdoaWprbG1ub2N0dXZ3eH l6e3x9fn9xEAAgIBAgQEAwQFBgcHBgU1AQACEQMhMRIEQVFhcSITBTKBkRShsUIjwVLR8DMkYuFy gpJDUxVjczTxJQYWorKDByY1wtJEk1SjF2RFVTZ0ZeLys4TD03Xj80aUpIW0lcTU5PSltcXV5fVW ZnaGlqa2xtbm9ic3R1dnd4eXp7fH/9oADAMBAAIRAxEAPwD1GtjDWwlo+iO3kpemz90fcmq/m2f1 R+RTSUx9Nn7o+5L02fuj7kHNz8PAodkZlzKKmCS95AEf6lPiZdOZQ3Ip3em+du5padDt+i+HJKS7 Gfuj7lWzHPopfbXWx2wTtOk/yf5KtFUrKeousLt1RaDLGmY+cN+kkoL13+o2poqa22xge5p1Ddwm P5XCF9sNV7se+phs9npuYNHGzeAHbvoe6tSfjZ7cpuRU9nvY1t7XTEt3fzft/l/vKGZ099hrvrt2 5DHh25xgOj6LHe3+Sku0vzS25D8e6oWsrNVu4bmggtIG4aa71HIvtppGQKq3VyyWH6UPLWfS+ju9 6fJ6ecygsyHQ4gAFhIjVrnRp/JU6cbIdUyvJLXNZGjeCW/Q3aJI00/FPUGWVss2Ab2h0QO4lT9Nn 7o+5OAAABoB2TpIY+mz90fcl6bP3R9yrdS6lV03GOVdXZZU0gO9FhscJ0Dtjfdt3KWD1DE6hjMys OwXUWfRe3/qT+65GjVqT+mz90fcq+c1raQWgA7uY8irMqvn/AMx8/wCBQU//0PUqv5tn9UfkWP17 ro6bldPx2va05WTWy3dqRU4W7nfyfdUpfWTrL+idCf1GtgsfX6bWtdx73Nb/ANSuY+slfTutswur XZPosdRURRXtdbY5+93o0Ne8N37rv5f82nxjsTtsp08zDwuu9YDeo9QnHY4Nx+lVuG21o9/qZTWF 1jvUc3fsf6XsYuqrqrrYGVtDGDhrRA+5Y/1W6N0/pvTa34dVlZygLbTcT6hcR+e36Ff9VjVtoSPT oFKSSSTVLHRZPU8m3cyyl00VGbS3WAYd6pj82rZYq3WM/Md1I9OocyullbLLy4S55tdY2tjP3Gt9 D9L/AMYr/TBW9jntcXgEtDjEn6Jc47Pb+41Gq1Ui6d1tlobVn7cXIcJYHO9lgA91lNn827+oyyxa oXK9S6FgYl1WEWuf0zqljvXo3Hc25jX5Nd9Vv09rm1ei+p7lqfVXLuy+iUPvO6ysvoLwANwpe+hr /b7fc2tEjSwp10kkk1TC2qu1hZY0PYeWuEg9+645uT0noGZkU4XUHYzW+pu6XdIYHkF3q4z7Qz85 rHMZX6rP5xdosT624mJd0bIuysV+YygeoaanObYQ36Rq2T+ka1zvpJ0d67qW+qXWrOsdPtttcHW0 ZFtRLe7Q7dQ7/tl7Fp5/8x8/4FcR0nrvSOifVjMyek7ha8+qzEyHNNrLHbaDTaxrt36Nzdy65uV9 s6ZXkxt9QnT4F7P++ozjRJqhan//0e0+sTMbqdDPq455qycykX0vLZbFL6zYDH53uXN/VH6uUdO6 9jDqNws6iKTfVjMbuY1p0Zc+54/nPp/zau/XvEuzaMS3pTjZ1Hp+tldLotFVoNO9rPpOZ6rNqJ9S 66Kcx46gS/6w5Nbr7wZJZS41iqtxjbU/Yyn9F/LUo0gaO+4/l+ip7MJJBZXXOiP6tXS0ZV+KaSXA 49hrkn9+Gv3KIeKnVSXj2B1HJf1S/D6j1zJwsbHdZX65vc0FzHbGt3Ftv0/+LVrqvVDg1Nt6X9Zc jPvFjR6TbjYA3Xc536Gtvt/lPU3sHv8Ahoi3svrT07KuysbPwMZ+TlUBzC1tlddbmkhpryPV2vs/ Rvt9PZ/NpsLO65ilxHRbnGyNw+048SPzvpt/NWfR0vqPXfq5j9U6hl5WPm1UWlnpWGkPaC99Ft9b G+9z69i5X6uZmFkm79udbycFo2+gRk2M3E7vU+l6v0falGFgjfh8L/7pT2nVbfrTmOrso6R6NlQI Y5+TUQ3dG5+1jm/pNrfT+n+fYug6RSaOmY1PpGk11taaiWuIIHu3Pr/Rvd/LavMOtZ1GH6P7B69l ZjnFwui9z9sD2/mVrpOs9Dycv6vjrmblZdPUqMFr7KqrjXWXsbv99Vf57v8ACe9Iw0iD6bPY8X+K p7dKV5J9X7OkZOI53Weu5GFlbyG0/aXslkTu9wt/6tRyOo5WF1Oun6q9Uyc9lgbq6x1zXPLo9P8A Sta3Zu2b0jh1Is6dTH0/4yrfXUjqIPCasuLG7vpQN0ePdOeFCl85659W8Pq/X89uDcKcul7Bk49r PafUaHetj21e33U73u9T/CLpsDqmJltysHDDjX099bTa7Tc61r8j6On0Ny5/649NOf1izI6RYWdV w2sZkUh2x9rXgOpso0/SbaX3+rtsr/m1qfVnp1PSOm29Nc9tnUQ/1sza7fG8OZj7nw1v81X9BSyo wFnpoP2q1f/S6b624HVMcUdb6G17sxjBRk0MG9tlTjvY59P5zqrnblQ+o7jbl2/WDqVhZfn2uw6d 2jS6KtlVe73N2+hZX/YXT9bPWa+nV39GdX9pq2zVawva9jhsc39H+kbs/nPavPeo/WuzqQw8T7Mc XJx82u81zIDw524e8er7rbvoqaFyjWnn+lwqfWBwsvrn1h6d0Ouq3Ps2NucW16OdJA3R+iZYrXTM j1cDHc4g2iqv1QPzXFjXlrv3fpKp1vD6tlClvTjjbWkm37ULD4bfS+zvr/lfTUQq9f4f98p8o6bk /V89Zyb+tVi7Bvfba2s743Pdurd+ha6z6O5XOtX/AFJtxwOhYvpZjns2uZ6oET7/ANHdW1ti7l/R vrQSNr+mgRrLMg/+7ClT0n6112B7b+nNI7iq8x/nZKn9wb3/AM6Vf4vAinn+nfWl/R/q2zE6uXOv ymXDAY9rgfRA9Gtp2Ms9m76Hq+n7FzX1cv8AqxR6w6/jNygQ30N287SJ3x6DX/S9n0l6c/p/1ntI dblYJcNJFFug/wDYpcp9YvrT17oXU34Dq8S8tYx4sFdrZD59u37Q76O1KErJEQLlqeGRj9noVTh9 fu+rVwpb9XcL0Lg4utdULXEiPo+k9jf89bub9abMP6sHofVPUd1a7Eh28PDgLZ9Pe9tbqt7Kv+FW j9VOrfWTruNfk0vw8T0XiuDTa+dN8/0hvitl+H9byZbl4BPiaLRp8slCUhYB/RN6yPF/jcKqfOfq 5k/U6nCc3ruI3IzN522uFpOyBtb+iY9vtQ+pW9Ov6jWfqnj2Y7W1gAY4sJ9QulrmiyvdV7tq9Edg /XSdMjpp+NN//pdM3F+vbJ2X9Laf+LvP/o1H3BZN79DKRj/i8Cqd3CFwxKRfrd6bfVJ537Rv4/lI ltjKqn2PIaxjS5xPAAEkpqRYKmC6DbtHqFs7d0e/bP5u5Yn1u6lRR0TqOOyxv2o4r3CqRu2O9jn7 J37VABZrul5H6039Q/bmP1foQe85rXUg1jcHWUPsxOI/dd+c1dH9Xek52B0u3I6o57+p5ls5D7CC 7awGqhktc/27G7vpLkPq/wDWjqzMTD6R0jGa/KJc0ZLw57a3WuL3P9KsfmNc/wCmvRKsO7D6a2m/ IOVaHkvuc1rSZ3R7amsZ7WqTJcQImh/0jFT/AP/T9Sr/AJtn9UfkXLfWzK6Lg5VGT1TFNYrsrfTn sbW/9IC4112t/pW32v37F1NX82z+qPyKGTjY+VS/Hya23U2CH1vG5pHm0og0bKnz7B+slI+ulNmG 82YXVPSY+NzAHtY7HaTW7b+c5i7/ABcyjLYbMd29rXbXGCIMB35w81yvVvq39W+l5DOoV4GYx1Th c12EC+trmuaW76Jd+d+7Wuff9b24X1g+39ObZTjZQrGfQ+tzQdhaz1q6Xbff9nb6e9SGIn8oOg6+ Cn1JJYln1q6ZjZFdWfZ9mryGmzFyXD9C9n/Htc9rLNvv2Wemthltbo2vDi4bhBBkH87RRkEdFM15 l/jQo29Zxbjxbjx82Pd/6UXpiyet/VnpPXXUu6gx7jjhwrLHuZo6N07D7voJ2OQjIEqcr/F9S3D+ r/qOMC+0WD+1XURwupZY2xu5pkcKjX0nGxsCvCxQWVUhrWAmdGhrBLjP5rFZxccUsAJk8c9v/JJs jZJ7qbCZQsuqqrfZY9rGViXuJADR4uXPj66dOyGW5WG42dPxmEvynNIY+yN/2fF3OY6+302P+jX/ AG0hEnZTuWZmPVlU4j3RdkbjU2CZDBuf7o2tXmtPXOiHqvVs/qr3enmOsoFYYbCaS6ptbG7g5vv9 L6D/AGIX1Z60X9SyOo9W+2ZObaCyn0Kn2ljHH1rWUtDX+m3ft/62u36N9Wfq9UyvKp6X6FgJcz7S N1rZ8d77tikoY7ErN9kJvqvdiX9MY/Bw/seEdMadgdY0D+efXR7K93+etDO/mPn/AAKsta1oDWgA DQAaABV8/wDmPn/AqM6m0v8A/9T1Kr+bZ/VH5FNVq8qsMaDMgAHjw+Kn9rq8/wAP70lJHsa9pY9o c12haRIPxCx+o/VnCyWzjUYuPaPz341doIjja7Z+d/KWp9rq8/w/vS+11ef4f3og0p8/639Uvrbn 1V41hpyKKj+i9OqurYB7QGbsl/t2/msUr85/SeltxM3rAq6xiD9C9jwXxr6eLk44tyK8hnucze73 /wA3/o13v2qrz/D+9VsnH6blEm+svJ59xH/UvCd7h0B2GugCnk/qx/jAuycmvp3VGte9ztjMusOG 7R0GyljbGs4Z+fWu4bdS/wCi9rvIEKlTXiYlTmYbNjjO3cSWz/KlznKvkYdec1oz7Nzmmf0Ldg/6 b7fzUJGJNgcKnUtvpr/nHtZ4biB+VeffWD/GNlDqFnTemGrGo3Bh6g/Vw/0jm02itrNv7z11VOCc EO+wZB3OMxewPH/gTqHKzfidNy/dlVb3uHvhzgJ/svalAxBsjiU8rVPWekHBxPrA1+VlNnKcXNss tc6D6dYbdV9mqY1mz06VLB+qP1hx6Rgi7Frwmu3hhxK3Nk/Sd6f2jbu9zvprrMWnp+I0Mx2FjRwJ J/6p7lY+1Vef4f3onIem3iIqafTOh4mCwTVTZd3ubTXWeIdtbSxu1aSF9rq8/wAP70vtdXn+H96Y pMq2f/MfP+BU/tdXn+H96BmXtsqDWAkz2+BSU//ZADhCSU0EBgAAAAAABwAFAAAAAQEA//4AJ0Zp bGUgd3JpdHRlbiBieSBBZG9iZSBQaG90b3Nob3CoIDQuMAD/7gAOQWRvYmUAZEAAAAAB/9sAhAAE AwMDAwMEAwMEBgQDBAYHBQQEBQcIBgYHBgYICggJCQkJCAoKDAwMDAwKDAwMDAwMDAwMDAwMDAwM DAwMDAwMAQQFBQgHCA8KCg8UDg4OFBQODg4OFBEMDAwMDBERDAwMDAwMEQwMDAwMDAwMDAwMDAwM DAwMDAwMDAwMDAwMDAz/wAARCABLAGQDAREAAhEBAxEB/90ABAAN/8QBogAAAAcBAQEBAQAAAAAA AAAABAUDAgYBAAcICQoLAQACAgMBAQEBAQAAAAAAAAABAAIDBAUGBwgJCgsQAAIBAwMCBAIGBwME AgYCcwECAxEEAAUhEjFBUQYTYSJxgRQykaEHFbFCI8FS0eEzFmLwJHKC8SVDNFOSorJjc8I1RCeT o7M2F1RkdMPS4ggmgwkKGBmElEVGpLRW01UoGvLj88TU5PRldYWVpbXF1eX1ZnaGlqa2xtbm9jdH V2d3h5ent8fX5/c4SFhoeIiYqLjI2Oj4KTlJWWl5iZmpucnZ6fkqOkpaanqKmqq6ytrq+hEAAgIB AgMFBQQFBgQIAwNtAQACEQMEIRIxQQVRE2EiBnGBkTKhsfAUwdHhI0IVUmJy8TMkNEOCFpJTJaJj ssIHc9I14kSDF1STCAkKGBkmNkUaJ2R0VTfyo7PDKCnT4/OElKS0xNTk9GV1hZWltcXV5fVGVmZ2 hpamtsbW5vZHV2d3h5ent8fX5/c4SFhoeIiYqLjI2Oj4OUlZaXmJmam5ydnp+So6SlpqeoqaqrrK 2ur6/9oADAMBAAIRAxEAPwD3dYWts1lbM0EZYwxkngta8B7Yqivqdp/viP8A4Bf6Yq76naf74j/4 Bf6Yq0bS06ehHv8A5C/0xQWO3/1qDW7NLQQPpy+pJqkLQqPSgSNijqwAIcvQAHqpbYYso1Rvmkur 6xdW+j6Z5qtmtlsLqa3eSweBCHsZ2Bd+e7B1irJX7OxBHfBbZCFyMTz/AEu1bWLvTNJ03zPzt1sZ 5IpbqxaCNlFjJG0zssgAbnHGOZP2Ph+z3wksoQjKRii7ibVIrry9d2/1eW31W5jiu7A26EJBLA8p eN9mqhC1Jqpr0GC2MIg3fRmIsrQf7oj/AOAX+mFqb+p2n++I/wDgF/pirvqdp/viP/gF/pirvqdp /viP/gF/pirFfRj/AMZfV+C+hwr6XEcP7jwpir//0PemnbWFr/xhj/4gMVY/5h/MTyh5a0/zBqOq alGkXlhIn1mNPjlha5QPDHx7vKGX01/a5LlkcciR5qkv5V+a/PHnixu/NHmXRB5b0O8df8O6RPyO pG1FT9Yu60EbSVHGIL8I6nDlhGJoG+9XoTKHUq3Q7Ghp1ypUqtvLekWUnq28UgarEq08zqxcUPJH cq2x7jBTMzJ5oGTSvLHlLR7m6NusGj2FvNK8cjPNHFAqM0ixrIzBVKgjitB+ziBZpZTlI2TuoeWb TypqGkejpcMb2MaNaS2jyNOsCyRgtb0cniODL8I24kfs4SFMyTac6boemaWka2cJURL6cLSO8rJG P2VMhJA26YKUzJ5pnhYIbUIbm4sp4LO5NndyoyQ3SqshidgQr8XBVuJ3odjhBV5N5K/MvzZp2s3n kf8AN3Txp3mCzjnudL8wWkbLpWsWdqnqSPEatwmRAXeEmtK0+zl2SESLgfh1YvU9E1jTvMOkWOu6 RcLd6VqUEd3ZXKfZkhmUOrD5g5VKJiaPMMki/wCm5/2H/MnIq//R9n61530HydF5Xtdbn9F/Md5b 6Ppxp8JuZYmdeRJFFPHjXxYZOMDK66K+btG8pfmjq/50edo7fXNM0LTPMWqtqVpPepDqWoSWum0g hns7J2KpwT4FmmARWrwBbMwzh4cdrq/me9X1ppVi2m6fb2L3U988Eao95dsHnlYDd5CoUcj3oAPD MEqjMCrJXEcbOSAqgkk9AB1JxV5Lofn64/MW4hubC1+q6BM4fSRNRpLuNqmOZ0/ZVkDSlP2YTHy+ OZQl0ocBo81Y15v8ua35A8w2GqaFqcunaTrFzHplnrMahzZXs542lvqUB+C6snciGOT4Lm1qieq0 dONkDxA3uedffw+avUPyu87n8wvJOmeZ3thZ3k/rW+oWikssV5ZzPbzqpNCV5oSpP7NMpyQ4JUOX 691ZllauxV4V+fPkmT9E6n5xsvPV/wCUYPTSPVEnD3+ilGHoiSSDi7W5HL454acftOPtHMrBIkiN X/ukHkl/5MeZdO/KryR+Xv5a6/qcOq6zrt9fafpdxYSie19FTJdROj94ijxhKd5AvbJZhLLOUwKC IvWf+m4/2H/MnMNk/wD/0ut/85D2ln+adra/lloF3HY/mJ5XOl+YdOS9f0Iri1u627tDMK0aEkO5 /Y4hsz9MTj9ZBMT6dkEsu/5xk8n+WtD8qXnmDTdRbzH5h1e8lh1nzVJyYXklm3pEWzyEu1shBEbG nqEF/DKtTklKVEUB0SHuM88NtG01xIsUKCrSOwVQPckgDMVVJNQsZKGO5iev8siH9RyXCe5FhdK8 M0LoeMkbqVdQQRxbY1ocBBTYfKejN5w8i+YbzTtC8oT6l5b0i5ePy1dpr2jxzmzqy+lJHNKA0fFm RC3GX0vSWT44UfM4iOQWSQeuxYE9xHzZD5383fm5530y303S/wAt47aaC5ivoUufMOkyqbi2b1IW kjiclljkCyBAy83RQzceQMYQxxO8j8ios9Q9T/L79AeSfJeieXroW/l67t7ZZLrSr28t3uY7iZmk maSRCqyM8hZ2dQFYnbKJcU5Ej1Mveyr/ABN5cNKavZHlsv8ApMO59viyJxzH8J+S2EzSQSAFd1Iq D2IPfK0qV5a219aT2V5Ek9pcRtDPBIAyPG44srA9QQaHG63V8EaL5W/LzyH+YWpfmVpmrPbeVvy6 vNRk1PynfVTUrXULZWS3t7cAlJYLhj+6koGolG+zm4lKc4iBG8v4unCx4g+rP8U3P1f/ABt+j3+s foP9Mfoqvx+p+j/rHocqda/BWnXNTw70yf/Tlf57aH5a/Mjz9DYpr3+C/N/lGzittZmvV4i/8uXk Hqtd2jIR6hi5yxtG383H7ObTTSljhxAXGX2S81fQX/OP2s6Rrn5UeXr7y9ph0ny8BcW2j2TsWkFn a3EkMckhIH7yQLzk/wAtjmDqAY5CJHdWa+bvKuieddAvvK/mOFrnRdRQR3lurvFzRWDgc0II3A75 UJUbHNX5y6p5I8r6F+fHmjyXB5R1rzZ5b0uaSKx0HRbqVb9B6cMglMgPIxoXYGp/aUds6KOWXhRJ kIk9SGsgdyJ0l4vKX53eUk0Wx1v8pNHWa3OoHzReXEryoJg8lS3wmORaQhasnJuTsmMjx4zZGQ/0 WNC0/wD+cmPyu8ieQvzQ8n2/lfy5LcWmuk3WpaPbyyNNfTG8CtFCzlijzBuI47VIOVaLPKeOXFLl 17kmI7mM/mz5b8v6b5dhu9D/ACa8xfl5MbmMTa1qlzcSWvBgy+jQswDMaEMaHb4d8swzJl/eif8A RWvJ6n+dvkP8v9Z/5xy0n81DcReZPOlrp2jaannDnM5nSOVbeWsTnjUEuvxpzDbua5jaXNMZ+DkN /SnhBDzaTyl5VP5aLfwfkL5iXWhpom/xY1xN9QDrFyN6ESv7utXC8KcaV2y/jkMleKP6v+9RX9F9 Lf8AOFWom8/LC7tZfMX6aurXUHLaeWdm0yKSNDHATJ1DUMo4Exry4r0zX64HxOVfpbAX0k/2TXYZ r0vgb8xrb8rfMv5p+aPM/n+4Gg3HlLU54PMui24Lvr9rbKG09rZCdp5VUQ3AHwsvB/HNviOSOMRj uJj/AEqKD6g/xBrP1D/FP6DH6X/Q36Q/w16q0r9V9X6v6lOPLj8HTjy26Zqq3pL/AP/U61/zlB5Z /LbzHpnlqy84X0nlnzPPbPF5Z82yQM+nCZVUtZXcg2USV5Jy4925faDZ+lnkgZGO46xVPPyA8+2c vnDzD+UWkyR3HlXyppuly+WbtChZ7c2sK3RZkJDcpnEla/tkZHUY/RGZ5yJV6d+cOsT6F+Xeu6nb a4/lq4ihRYNdjtH1BrWV5UVX+rxpIz1rxoFb7Vcx8IuY5HyJ4R/plfDtvYy6P5sufO2m/nNeW3nD Ulc32qQ+U9XeaVZCoYEG3ZKHgvRR0zdWCOHghXd4gYcP9b5JxFonlzz15l03Vvzb/MvXfOlnpZX0 9Oj8qavBzj9RXaPkLdVRZCoDcU5N05ZAylAHgjCF/wBMJ4T3FCeeNCttR1i386+b/wA3dVtptNuO Gi39/wCUtWgisv3plghiYpGgKEbVFWIxxZCfTGEfP1j1MSiLmW2/NSyfy9rf58a35q0eJluL6wsP KuoTtQP8DMkaU2YfAWDAP2ydeF6uCIP9ZAHvRvnXy35L1HQ4PJGk/mH5k0L8ubS3gji8r3PlLVrm NrqA85biWQRRMzSyM0jD7IJ+WV4MkhLiMYmXfxhlw+RQba1NBoA8rSfn/r0Pl8Ww08WR8namii1E fpekG4BqcdvtdNssERfF4cb/AK4YEEfzvk+g/wDnFLRvy20Py5rVn5A1e91y6FxCdb1DULG400mT 0yIUihnjSkaqGpTl/lNmt1fHxDir522APVfzP82N5H/L7zN5rRQZdI0+e4gB6GcJSIH25lcx8UeK YHeUl8h6VbflL5y89+RPNPmaa781fmXrOm6Slx5V0705Fm1O3jUy39/JyVYo40VWeNiC3D7B+zmx l40YSA9MehP6PJjxHufXdT/jj39Pr/zwzUdGb//V9sa95S8u+ePKo8veadPi1LR7qGP1LeYbBggo ysCCjD9llIIyUZSibBpXxzNafl/+Tdv+Yb/lb5sn07z2sVsLPQ9X/wBF1KxOn3K3DwUnC/WIZ1U0 Yc+S0X4uStm0icmbh4xce9hxi6fWn5Z/mFpfn7ydoHmGCSJNQ1fT0v5bBWUSIVYwzUjJ5cVlVkr9 BzW5MfBIjoGbOMrV2KvE/wDnLLRl1n8i/Mp4c5NN+q6kg7j6vcIWP0KWzK0hrKFeL/8AOB+mw2sf njzBIQqK1jYq5oo6Sytudu6Zm9oncBX2fBcw3Cc4XWRK05IQwqPlmoVV3xVAarrGmaJZSalq93DY 2EXESXNxIsUaliFUFmI3JIAHfALPIKXyV+Zv5h+XvOf5mefvJPnTzWnl78v9K0g6FCGkCBtQupIn ubgR7+tLFw9KNaNxP7O7ZtMWGcYRnEb/AFNZ5vWfyD/LH8sPLWhp5n8jaHe2txfqYl1fXY2TU7q2 B2kCSUaKKQiqrwiZgKsvTMXU5ckzUjfl0Zhn3/TcU7+n/wAycxkv/9b3np4BsLWv++Y/+IDFWEfm X+T/AJC/My05eaNAh1LU7ZCLG7Dta3SnsguI/jCk9iGUdeOW48s8f0mk2+R/Nlh+Znkb/DOn+R/y 18y6Nqvkq8upNG1YTJrUUttfy87i1kltEHqwSsA4DqGXoc2eLwzZnMHiH01yXd9Ay/8AOSVp5fl0 Cfz55fvPL2geYIYwurTK4/R2oUKy2uoQSIskQDAtHKA6SRfH2bMMaYyJESCR/svcg7PYdO80eXNT vZNK0/VrW71OCOOeW0imR5hDOvOOXgDUo6mquBwbscxTEgXSrvMnl/S/Nmg6l5b1iIzaTq1tJZXq IxRmhmUqwDLQg0PUYIyMTY5qwzyX+S/kz8ufLuo+W/KMVzaWWp3H1u5e4ne7kMwiEQ+KSppxA2y3 Jmlk3lzVlen2en+VtLklvbxYbO3UNNd3LrFHHHGCAWZiBsOrN1yoC0WwTz9+e3l3yvDo1p5YhPnD zT5kT1fL+j6bKgWaAkj61NO3wRW4I3lPX9muZEMBl9RoBSafPf5r61+afnf8zvLkV55J1rXPJnlM w3D2miwTfo7UdZjpK06SXQRJYYpOMcbNTkiPJ9mSmZmDw44yOIRMu/egxIk9t/LP8mvKT3U/nfzP +XNvo3m2+uGv2/SV8NavBPMS8kr7ehE7MalYq0+5Rh5M8z6eIkD4MgHt4UDoKZjJYp/03P8AsP8A mTir/9f3pp3+8Nr/AMYY/wDiAxVFYql+r6Lp2u2E+l6pEZrC5Qxzwh3j5K3+VGVYH3Ug4QaQQC8O 13/nDv8AKXW7g3D3GvQqW5G3GrT3EXWtP9L9dgPk2ZY1mUcq+QSAB0eYeefyD/OK4fQ9J8iaHp2j 2HlQtD5b19NduJtXhti3IRG4kiicRVJPpH1FT9geN+DVQiSZ3Iy+oV6VIt7v5F1n8wvKXl220j81 NV0fWvNiKXQWMzRXktuOjNGY1EjjoXREVsw8nDKVwFBQE3k/NG2UFL7SbvQvhDG48wIdOtKNXpOB KpoB02yoxPTdFvnT8yvyn/5yV8/+b4NW179D+afJdvOLiy8sW2pPY6U0YIKGRHiDSHYMWk9Sv7NB mzw58EI16onvq1p6NH/zjjoH5gXEnmX8zdCOjebHCRGbQtcvJlaKEBY1oY4Y0CKoVUROKj33zF/M GA4cZ9PmEjbm9M8hflB5G/LeSa48s2lwL65QRXF9fXdxf3DoDypzuXkoK7njxynJmnk+r7gigzvK kuxVif8A03P+w/5k4q//0Pa9ny+qwcf0nT01pw48KcV+zy7eGKoj95/2tf8Aknirv3n/AGtf+SeK u/ef9rX/AJJ4q0eff9K02/k/hiqUw8/05P8A700+rp/dcf0h9pv7zv6X8nviqNv+f1Kev6Rpwb/e jh6P2T/eU/Y/mxVdZc/qkFP0jT01/uOHo9B/d1/Z/l9sVRH7z/ta/wDJPFXfvP8Ata/8k8Vd+8/7 Wv8AyTxV37z/ALWv/JPFUi/d/wCJP+Pn1uP+X9d/u/8AgOGKv//Z ------=_NextPart_000_012D_01C5CCC2.CCEF8C60 Content-Type: image/gif; name="Reli75.gif" Content-Transfer-Encoding: base64 Content-Location: http://www.critteradvocacy.org/images/Reli75.gif R0lGODlhSwByAPcAAP///wgICBAQEBgYGCEhISkpKTExMTk5OUJCQkpKSlJSUlpaWmtra3t7e4SE hIyMjJycnKWlpa2trbW1tb29vcbGxs7OztbW1t7e3vf39//39//v7//n5/fe3kpCQv/e3vfW1vfO zvfGxve9vfe1te+lpe+cnO+UlOeMjO+MjOeEhOd7e+dzc95jY+djY95aWt5KSt5CQtYxMdYpKdYh IdYYGM4QENYQEM4ICMYAAM4AAFJKQv/nxmtaQv/WnJRrMbVzGP+UAP/erf/OhIRjMf+9Wv+tMf+l Id6MEP/Oe//Ga/+tIc6EENaMEP+lEP+cAP/nvf/epf/WjHtjOf/GY4xrMf+9SpxzKf+9Qv+1Ma17 Ie+cCP+lCP+lAP/vzlpSQv/enGtaOf/WhKV7Kf+9MfetEP+tEPelCP+tCP/OY4RrMf/GSpRzKf/G Qr2MIcaUIbWEGP+9IdacGOelEP+1CP/vxv/nrf/Wc//OUrWMKa2EIbWMIc6cIf+9EGNaQpR7Ma2M KdalIdalGO+1GPe9GP/WUv/OMf/OKd6tGP/GCP/njP/ea4x7OYRzMaWMMb2cKcalKdatId61If/O EP/GAGtjQv/ne+/GIf/WIf/OCP/vpf/vnHNrQpyMOcatMbWcKf/eMefGIe/OIf/WGP/WEP/WCP/v lP/vjHtzQoR7Qq2cOf/nUq2cMc61Kda9Kf/eKda9IffWIf/eIf/eGP/ve4R7Of/nSrWlMb2tMf/n Qv/nOd7GKf/nKffeIf/va5SMOc69MdbGMdbGKd7OKefWKf/nIf/nGP/3jKWcObWtOa2lMf/vQvfn Kf/vKf/vIf/vGP/3a//3Uv/3Sr21MdbOMdbOKe/nKf/3Mf/3Kf/3GP//71JSSv//3v//1v//xv// vVpaQv//rWNjQmtrQv//nP//lP//hP//c4SEOf//a///Uv//Sv//Of//Mf//KVpjSjFCUjE5Shgp UhAhUhAhWikxUggYWiEpUgAQWhghUgAIWkJCSjk5SgAAWgAAYwAAACwAAAAASwByAEAI/wD/CRxI sKDBgwgTKlyoEIDDhxAjSnzIrY2ZLmjoaETDkQsaLiC5dBH5pGQWLxNTqhSo8qGpPqMIjcI0ExMm WbJu4pTFq2cxZMFu3RuGDB8ybNiuNUua9Fo7p+3asSvWpaSSlg4FZojI7VXOPmBhxhw7qqxZTLPw 3aonq9POYjh5DcMn7p2+Zrya6d3bFFvUa07ZlXzCQ6JWhxqW9exjhrHjsKPEwhQr02zZWWXRzpJV rLPnYj6LNXO2d2lpwNh4jTSz4SFLh9FI9+HI0UzGMfZy49u9O7e8PJP6yPyCTzfv4vbwzZp1c1Y9 5MdzJ0dauhiaLktc/4voDnAQkUCuiP8fT/6KG0F0GM8JJIi9oEjw4Uu6NIpU2TiX8u/aFSrU/v2x FOMMTsW8wosZGmkD0WsSqeNOO81w8YSEE4rk0YW1aYSgGfsglxwjYbzRRxhTSAKJGmZVlllmmMjU xyEpHYaVQ+08+NRgVY3UxUgX0qGGdD8k0lh6YYFFiHB92DTKJKPMqN1WTkb50AbefBPOleHUoY0G UnbJ4Ag52ECCCjrkAIAJOehgg5gAlPnQCzqc4BANOZAAQw5ycoCDDjXYgEMJAIygAw0AcKADDg+V ySUAaUakw6MmLLjdRDLgsGYNIABAg6U20LAoByzkkCYMmTpUggyi6gAoADBwCkMHD4H/0KcKEPVZ 6go4tDARgxCFUAKsD/nKAQAllCCCQySw8MIKI0SEwgsulNDamSVkSkIJ10r7ULEhmLBqCcN2UEII uw7kQEQZEICBRBMcINECAh0wLUQP/BOAAAMJcO+08Ap0r734AhzAwPcG8M8AAzCk8MIMN5xQlxBH 7GQGBkwQwQIHWJDVpFFqs0gikMHFE2ed9bQUJ+5Yo1dSzQAGWFTt9DFYEFYMKyWvEZ2ipGWW0TRT TjjFUk8xtThzizO8FPOLP9S4Mw0+yZzGFFRQtROEVStx7JAxBhYJmRkpxqRiWaHQc8soz4giizHF PENML0W54wxoopl8WstIPRXVE1VF/8QgNKQRgsaGY1TxBT26+bHDPoxLh48akOThiDzI4XILK46w Ah0qu7hCDOL4yKNKMsiU/o5uv3SXlCzXZaHdQ94gxYuFHqFBiR7J0aNRH+kJgnhyYE3Cz24JgFXW JIwg548xy91DvDFsd+YMdMjkxYvgXUTxOkTcsONXH0jkTs/48txzTz388LNPAjt88UUPPUwxRRUe SseIGqhwwkkPfvgBzjbbSEAC9gEPfsCjHuaThzw8EZn0oERSLQkHzK5xtZLQzkK0qQ0a3CAde8hj EGAZBCemcCQjkWVsJQRDS3AmJQ2Ew0EPcgpeRoEg2oCEI8bjSdI6M4tcbGJREeMVCf9a4IIWrIBc xCoiEUGgghcgEQArcAGwAACtFwTLBUVcQalG8AI5tcCKDhFBFznQAiIW0QUsaEEKHAKCFsCABABg kKIA0AJRlUBUaVoBAFhQpjLdMQciENUT6wiDGuAxBzI4lqg0oAEb4HEGgUQUAEiQgxlERFRg3J5E 0lQpHegqTTZQFJoyCQBDhiAGqmJVDnBgqVCpSU3NAoAMdAACNOmKVTVoVQt0AAMbkFI7DgumMIc5 kAdkZQEOkcC6AFAAjhXAIRX4R2sykDCHZMAByHRIAyZlMwAswGYVeMADBjCsbHYTAANwyAQoAK+B EURi8Iynk1goTw3UIQ1riINtdrT/IzQsAQtUgIKCJLYuKGkSYoXY3WN4Uhq9MKMpL7vGgSRUlScE wQjwpOdENsGksdxEJzgxEE9Aw4xgoMId77AGNvTismv4pWrt4AUaBpOEKGnUId/gWRxqoqSP7oRA qbgFNYpBDXoAwx3w8Mc2VqqUpbS0aoIpSRBUmLWUkEJJRxrbfWaSmVmUjxN+yMY74FIgXjjDHvVg xnNWylKXtvQpUOGFVGP0D4MCYBObkcVksookmYxtp2mxRy22MYtfGOMtr0AFPZjhj3eYLC93cylE nzLTIFxFUgb1BmhkQaQi0bAsex1b2YyTnOMob6w7fGxDlTK1dsz0CXaAoEM08Yxm/2AiI2YwAz/8 0RsPjS8f9LjHI5hUD97uxri8Ma49AuQ80zoXH/RASktHURIxaFIaepkNbRBEB0DohhJ9SMQkSuG4 KSDpHbuBh2ViAR1P6AQe6WWGDomRAOkAg62p+YgZNEkLZ2BjFBiyTXd1MwU13K8S0MnHJI5EHHzc AxCsiDArHCcP5swCvviABzCmcYvRcUI38GDGXljXhTUcFBpOATBIPMDbDprWceDoUAd1Q+Pc0AMW vZmx46QjD2DMjRc0pIOJDwqAdiSFDhPiZxfOwOQzlOHJW3jykwdRBkJU+clWJgQhBqHlLQ9iEJcA 8yX6Q+b/SOI/wYgFTnhHB79p7f8h54gKhXgUEozUjiN0yK1CZ4yPBEwCEvsIRCAS0Aomjc0mNKEJ TjDRmEKUy64Q0YCN+lBBCYFkJB/JIG7p8IP6vaEMOxBRHwCxjSONRatlkUkizulmJ9noGtRNcoVu eMPaxEM6O0hPYyAzmchoeaujSMQ86woxdtioHbIwQ0l0hEE84znP6dG1WHZCChhBTEbx7IY05Cbd qbFsL9YrBtt08UB53lSe6JYYgzRAAx0061GFYiUINsAlN5lKBzF4yCznyKo4MUpV7M7Bu83kkFkC qpECZyQAUHAoVNpAkzDQAQvavSpUrapQq0yUDrjkgjQ96lAcUEGjGJUDN+YABXv/9ORDRt4mgj9k T5Ikcrpnru43r9xMGphBDkIgKhWIQAeWvFO+HfIoDoBgT3AMVAk0ICgzbWCVwFplDWjpEEPpQAYA +LkOfrmxiQQSBhAB0wsE9fCfIzIEJ2i3JV9QyWHdsQYcCKUMQhnLNNkd3nci16goeUs3Q5rmgLcp MRnizsEP05gQgdcyH3IBArjLzZOCgEAM8BAEPCQBCgCABRjgkAuYS/MQcMgG0gmAB2wlAgxowAEW gPlmfv4hGYDXBSCSAQkU4PFTChgBIvAQDDBAIMj0vAQA4PmINIDzxQcABMhZeq31qyB/D7z0qzr9 6j+EARXIwAZmv7HoWz/dG1A9/wMKoADex5HY6e6GFOJAh35m8NI74psThlBudGMbYnZYQ2cRBJOb sJQpeCELo/ARFFUSS6A9GWVzM0IGIBMWmJA0PRGBeNEMnKBSLYMaTSEVejUzThBE6DcjXmAIiVAZ IBUXESgaevEL2IAKbCVZTvEyUSFTUuUEUHAzH6gSimBomQE0PwUXJ+gJyfAOzQAMCiBipTE1MMgO 7TAzl4UV5wYAmtBRZ8FVPvVTnNELwjANzbAP9eA0/jAOp4EaMBgV7CBXFlVTK6SAiMEkNKEiO5Vo iAY0xfAOY4ULzAAa00MP7kAN9TAOTOVUTwUz7CALUjUvhqGGtsBVv0YWU4homP/ACP4gCvDgCbVw C68AGqPhD6kzHS1jGi7oMn9RWdlRLhPBDZsRE8JxaoxYE6NQDP5QC/XQCsVwNF7BCwbCCfgADAmA Dy3YiW4FVzDTDrFWfzJHC6SwZpXRGJXxVzMxC/7gCPfQC25hhXKBD+OQVKQBWW0FiDD1WlZwiBFh C7NQDJGxa5KRaqlGgqMgDv4wCwnACvDgCj1YD6lwVsEAGtazWheYFHozClUxikQWPeZoPDCRW+gY NqMACcnxDqxwC5fjCL9QC+OQG0EFgaoVWW7lFBPyBEB0fhDhC0kzCnlWJHxFQ31FFoMQQAAEQHTY ku9QFwy5WZgogWEoWe2ACRP/8o2a5A15wVnclQdXMAaAkAdu8Ah8wAeSEAiSwGUwQQh/ID9TUAtS yQhU+Qu/oAqPsAtwwQkJEECYxzgEBA9i+QvUoBSo0Q5mICEI6JEOYQq1NYAIUgbPoWM7thuM0Ae7 yGc6hg/vIAvNRZcupoJ7AWsiQQWaFBvNoF0aQQeJkAg/khsNCBaUkxzbMAmkQAq7mGGYMQvQ4ziV QDLPgQ8K4AykiQ3uAAy6cVIrMztd4DobsyjY1QxpSRuL6V250QgFpgZhUBzQFQiVQRy5AUB+sA31 IB2VABc3AV/2QA9gCQ+TaQ8sOJgy1QWE8CQOATjX0AcYgme4Yxy8oRv0kAdH/zIJ2wAd0WFjj4Bo yuk432kP93BfkEViZGCdAEAOznANmIBptUMHuAFdedYYZoAIv4MPYbEDxMMznwAdmDEKoZkAPTg9 utEJEwhgXWBdXecQ3AAYzUCAHBoG0pFnZZBbMpYcgxAJjqAb8hAJkrCUkvCc9iAJrbALKMoKngAM wIALE5kc9gAMJsNddUCf9QkYhLgjBgqYLrYDg9AhHtJbvLkbj0AKvUVjS7obnvBj5IggaNh9EOEM N5Jki0kHlKARlBCmibCYbAYyIBMcajoJbHqQZrEccMqZnUEyZFUMQ9JqEFEOXBohTPBcfmpaLcak pYUPyEWof3ocuKBXvHMHeP/KPeygkUq2I7WWQdA2kgjCZ/EQQmHACSDEMzxTgopKBz/qdxKRoTd5 NRQlEjySaYOTEf+ZHvSwpH4wCDsQCFPACZDgASpyaI4ogJFBjBcqEd5gI4RoQRZEO5qWWwgCnLrx Bz0ACX3gCPxQCo+AIovoqTQxGbFFiiphbE8hM4NRIas6qRoxBr4lCH0gCAmQB3mwA5KQik1ZGTtl FjCRhjNyDH9BaRspruNKG3MgD9LBDwMZFgbZlKs4CozqhGooEeUAMzJorBe0nx6aG1Pwn2AxsI1x FjRhCYInJd6wDjZyIMsWEiHxEZzGG2OgIQA6sKw4CYawrcMWMdxwDt0BMwP/eKy1s5+VqqwZC1Kj sArd4IHoBg01AlEs4xVocRP46BOcgROr0JFCC3jc8A3nIA3eMxqkyVK24AvhwGr2t7DfV31PGLaB xyu7hEc64BB3gkcgQCfHEm84UCok53IncEg1ACt19EkutwIlByZlIiq5IirHMksyMCwMoic4ACui knV8Qm8OwXJ8e0t1KwNTdyw5VydPB3cdwErDwnKhhESPMi9PVyY4kHTnByV8uyfuprZXV0b15nKO lCkdUCYbECpYVwJlcgIMlwMssAIqV7dDR3IaFxE6l7aY5RB70gGby7sh8HE5AHYm8CiiggKNwnZv dC06pwL7prpwl7yyJL1x/ztysxtzRIdIjUq2ZHt/6Gt96usQoZQqntJHaXJLhiS/NXBz0ptKdPK3 MrAobMdLEJEmkQIAewJ24DgRjfJzNrABj1ICbHdEfNJNjhQCIqcrGrABrbEBdZu2Iod1xJIDL7BL A4y7asIBrbJ13BoRDGwDK6ACcNQBiIQqkUK9cFd1i9tukUICJJC9qGJILqdzNjADU/dwd4Rydvdz fSdbEeG7KPcQoRIpaQJHDIy2cosmeEQoLdcCR3dyoeICiZIDf/S4LPDBSSxz6zt9Y3vGX2t4bNzG BYF4D+EA/7B4oncAuPcQBjN5ETEBeXwQGgMAcuzG5wIAB7Auo7dMCsB5AM0gAY93AZTnTQzSAAJg fgBgecT3D+6yAZkHANQEfACwAYpcL+rEfQ6RAAvAAAwQMAIxyA+xTXQMABiAAHfsEAkjAA7RL7j3 yACAeosceos8ELwnARVwfbecTA9wygqAAAzQx/8wyBEwLRGwTBMwAQ/xyBtgfqOngBZwLw4Bxwdg VxhgAFvxyBjAfRwwKQqwAAaQEI5nxwZAAJNnx3acMPbizgdgAMz8D+m8AH08AAfQTAOAAM0ky/KM MP+MyQgAz7cHz/J8AKrsxhDdxgEBADs= ------=_NextPart_000_012D_01C5CCC2.CCEF8C60--